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Candida albicans is one of the top five most common causes of nosocomial 
bloodstream infections, and systemic infections are fatal in 40% of cases in 
the UK. Treatment of candidiasis presents a challenge owing to a lack of 
efficacious drugs and a paucity of suitable drug targets for development. Novel 
drug targets are urgently needed in order to tackle this growing public health 
problem. Hsp90 is an important regulator of C. albicans virulence, but is highly 
conserved with the human orthologue, making it a poor drug target.  
 
Hsp90 functions in concert with associated co-chaperones, which are less 
conserved. The sub-telomeric location of co-chaperone genes is reminiscent 
of virulence gene families, including the TLO genes in Candida.  
 
The principle aim of this study was to elucidate the roles of five Hsp90 co-
chaperones in C. albicans virulence; Ssa1, Ssa2, Sba1, Aha1, and Sti1. All 
five were found to be instrumental in biofilm formation and in killing of an 
invertebrate host model, Manduca sexta fifth instar larvae. Ssa1, Sba1, and 
Sti1 were identified as regulators of fluconazole resistance. Ssa2 was broadly 
found to be a repressor of virulence traits, though apparently with an overall 
fitness benefit to the cells in the host.  
 
The secondary aim was to investigate the silencing effects of histone 




reduce silencing, while Hst2 was found to increase silencing of Hsp90 co-
chaperones by heterochromatin formation. 
 
This study enhances understanding of diverse C. albicans virulence traits and 
how the dynamic Hsp90 co-chaperone complex regulates them, as well as 
how genomic locale implicates genes in virulence functions. This may inform 




1. Introduction  
 
1.1 Candidiasis is a major public health problem 
 
1.1.1 Candida albicans is a leading fungal pathogen of humans 
Human fungal infections are a neglected public health problem and rates of 
candidiasis are on the rise [1]. Lack of efficacious drugs makes infections 
difficult to treat and a paucity of suitable drug targets mean there is a dearth 
of novel drugs. Identification of novel drug targets is key to tackling fungal 
infections. Hsp90 is an important regulator of virulence in Candida albicans 
but is highly conserved with its human orthologue [2]. Hsp90 acts in concert 
with associated co-chaperones, which are less conserved and less well-
characterised. The co-chaperones’ sub-telomeric locale is reminiscent of other 
virulence genes [3-5]. The principle aim of this project was to explore the 
potential of Hsp90 co-chaperones as candidates for development of novel 
therapeutic strategies to treat systemic Candida spp. infections employing the 
principles of evolutionary medicine. The secondary aim was to elucidate how 





The opportunistic pathogen Candida albicans causes both superficial 
infections of mucosal surfaces and life-threatening systemic and deep-seated 
organ infections. Incidence of invasive candidiasis in the UK is currently 
estimated at >5000 cases per annum, with an overall mortality rate of 
approximately 40% [6, 7]. C. albicans is one of the top five most common 
nosocomial bloodstream infections [8]. Diagnosis of systemic C. albicans 
infections relies on time-consuming blood culture, which fails to detect 50% of 
established infections, often causing delays in administering appropriate 
treatment and increasing the risk of death [9]. 
The victims of these infections are typically immunocompromised individuals, 
such as patients who have undergone surgery, chemotherapy patients, organ 
transplant recipients, and people infected with HIV. The increase in recent 
years, particularly in more economically developed countries, in the use of 
therapies with immunosuppressive side-effects has resulted in a larger 
proportion of the population being susceptible to life-threatening fungal 
infections [10]. There has been a dramatic increase in use of solid and fluid 
organ transplants in the last two decades, and for such transplants to be 
successful suppression of the host immune system is required. Therefore, 
treatments are needed more than ever before, while antifungal drug resistance 
is simultaneously an increasing problem. Perhaps the most emotive aspect of 
life-threatening fungal infections is their prevalence in neonates. Risk factors 
such as pre-term birth and maternal pre-eclampsia can predispose infants to 




C. albicans has the capacity to cause life-threatening systemic infections and 
the lack of efficacious treatment options, in combination with scarcity of novel 
antifungal drugs and increasing immunocompromised population, mean that 
incidence of systemic candidiasis is increasing [1]. Poor diagnostics and the 
evolution of drug resistance mean that we are ill-equipped to deal with this 
growing public health threat and that identification of novel and robust drug 
targets is needed. 
 
1.1.2 C. albicans employs a diverse set of virulence mechanisms 
C. albicans employs a range of cellular processes to facilitate its thriving in the 
host environment and subversion of the host immune system.  
The most significant virulence factor of C. albicans discovered to date is the 
cytolytic peptide toxin dubbed candidalysin. The first toxin of its kind identified 
in fungi, candidalysin damages host epithelial cell membranes and induces 
epithelial immunity. Strains which do not produce candidalysin are avirluent in 
mucosal models of infection [12]. This recent discovery is an exciting 
development in the understanding of Candida spp. virulence and opens up 
new avenues of possiblity for how fungal pathogenesis may be undermined in 




Oxidative stress is induced by oxidative burst from the host’s innate immune 
system, when immune cells such as phagocytes release reactive oxygen 
species (ROS) into the phagosome, which exert oxidative stress on the 
invading pathogen [13]. Pathogenic C. albicans cells are able to resist this 
level of oxidative stress and escape from the phagosome unscathed; essential 
for thriving in the host and causing disease. The Cap1 transcription factor is 
the principle mediator of the C. albicans oxidative stress response, inducing 
transcription of a wide range of antioxidant enzyme genes to reduce ROS 
molecules [14-17]. These include catalase and superoxide dismutase 
enzymes, located intracellularly or anchored in the cell wall [18]. Sod5 is 
anchored in the cell wall to reduce extracellular ROS, and is specifically 
induced by englfment by phagocytes, and by hyphal formation [19, 20]. C. 
albicans can also induce hyphal formation as a means to physically escape 
host immune cells, resulting in death of the phagocyte [21, 22]. 
The heat shock response is important for adaptation to the host environment, 
particularly when the pathogen induces fever [23]. Thermal regulation is also 
intrinsically linked to hyphal morphogenesis and antifungal drug resistance, 
both of which are major pathogenic traits [24, 25]. A temperature of 42°C 
constitutes heat shock for C. albicans and the heat shock proteins were 
originally identified by their upregulation in heat stress conditions [26]. 
Biofilm formation is a ubiquitous virulence trait where cells form a matrix of 
extracellular polysaccharides allowing them to adhere to diverse surfaces [27]. 




drug treatments as well as from the host immune system. Furthermore, the 
biofilm community can act as a cellular reservoir, allowing for dispersal of cells 
to seed the infection further afield. Biofilm formation in C. albicans is a 
multigenic trait requiring full functionality of six different transcription factor 
networks; Bcr1, Brg1, Efg1, Ndt80, Rob1, and Tec1, disruption of any of which 
leads to defects in biofilm development [28].  
The term morphogenesis refers to the switch in phenotype between the yeast 
and hyphal forms of Candida albicans. The ability to change the cell 
morphology is considered essential for virulence in C. albicans and 
morphological defects can make cells avirulent [29, 30]. C. albicans uses 
hyphal formation as a means to invade host tissues and disseminate into the 
bloodstream, and is thus a valuable weapon of virulence [31]. The process 
involves changes in cell wall architecture and composition, and can be induced 
through different pathways by a variety of environmental cues, such as 
changes in temperature, pH, or ROS [25, 32, 33].  
Drug resistance is becoming an increasingly common virulence trait in the 
modern world, and renders existing antifungal agents impotent [34]. Hsp90 is 
considered to govern antifungal drug resistance and the function of this may 
depend on its associated co-chaperones [35]. The concept of targeting Hsp90 
co-chaperones for treatment of systemic candidiasis may also have scope for 





1.1.3 Evolution of antifungal drug resistance is a growing challenge 
There are limited fungicidal drugs available for treatment of C. albicans 
infections, and widespread resistance to those there are, resulting in a death 
rate from systemic infections in excess of 50% [36]. The genetic similarities 
between fungi and humans also results in a paucity of suitable drug targets 
which can be used to attenuate the infectious organism whilst avoiding toxic 
effects on the host. The targets commonly employed in treatment of bacterial 
infections, such as the bacterial cell wall or cell membrane, are not available 
in the eukaryotic fungi due to their more recent evolutionary divergence from 
animals [37, 38].  
The problem of antifungal resistance has been sorely neglected, especially 
when complared to that of antibiotic resistance in bacteria. Whilst there are 
more than 20 classes of antibacterial drugs available, there are only 4 classes 
of antifungal drugs on the market today: polyenes, azoles, echinocandins, and 
pyrimidine analogues. Resistance to any of these is not uncommon [34] and 
most of them act similarly by disrupting the cell membrane or cell wall 
synthesis [39]. In 1997 the 30-day mortality rate for systemic candidiasis in the 
European Union was 37.9% [40], but by 2014 this had increased to 47% [41]. 
Such a dramatic rise in mortality rate in 17 years, in an age when efficacy of 
medical treatment should be advancing, must surely be attributable to reduced 
effectiveness of antifungal drugs. If such trends are allowed to continue, 




Of the currently available antifungal drugs, azoles are the most often-used 
(Fig. 1.1). They induce a strong selective pressure for resistance in fungal 
communities exposed to the compounds [42]. Azoles act by inhibiting activity 
of lanosterol 14 demethylase, which is necessary for synthesis of the 
essential cell membrane component ergosterol, so cell membrane fluidity is 
disrupted. Ergosterol is an essential component of the fungal cell membrane, 
balancing stability and fluidity; it fulfils the equivalent role of cholesterol in 
animal cell membranes. Growth of cells is arrested and toxic precursors to 
ergosterol build up within the cells, inhibiting growth and development [43]. 
The pathway of ergosterol synthesis is specific to fungi and, with very few 
exceptions, conserved across the kingdom [44, 45]. 
However, binding fidelity of azoles is not perfect and some side-effects can be 
induced in the host when azoles bind human cytochrome 450 enzymes, which 
are needed for a range of metabolic functions [46]. Point mutations in ERG3 
and ERG11 have been found to confer resistance to fluconazole [47]. 
The problem is exacerbated by use of antifungal compounds in agriculture, 
with herbicides such as 14-dimethylase inhibitors (DMIs) and prochloraz 
used extensively [48]. They are similar in structure  and action to triazoles, 
which are the most commonly used class of antifungal for treatment of 
infections in humans, and exposure through agriculture encourages cross-
resistance to medical triazoles [49]. Azoles are currently the most readily-




resistance to them poses a real threat to treatment of patients with systemic 
fungal infections [50]. 
Echinocandins such as caspofungin act by inhibiting synthesis of cell wall 
polysaccharides and are fungicidal to Candida albicans [51]. They are 
classified by a cyclic hexapeptide structure with lipid side-chains to anchor in 
the cell (Fig. 1.1).  
 
 
Figure 1.1 Structures representing two of the most commonly used classes of 
antifungals today [52]; caspofungin, from the echinocandins, and fluconazole, 
from the azoles. 
 
Employing essential structures of the fungal cell as drug targets, as is the case 




exposure to the drug, the surviving fungal population will be resistant. In 
addition, these are largely broad-spectrum antifungals and so resistance 
easily becomes widespread in fungal communities, even in the environment 
outside of the host. Studies of sequential clinical isolates from a single patient 
have shown that a fluconazole-susceptible strain of C. albicans can become 
completely unresponsive to the drug in under two years [53]. This occurs 
particularly as antifungal agents such as the azoles are used in agricultural as 
well as medicinal applications. Targeting cells specifically when they are 
exhibiting virulent behaviour could help to prevent the spread of resistance as 
it eliminates the problem of selective pressure on fungi in the environment 
outside of the host, or on those living commensally in the host.  
The study aimed to answer the question of whether Hsp90 co-chaperones 
regulate fungal virulence and whether they could be exploited as drug targets 
in the context of evolutionary medicine. Evolutionary medicine is the 
application of modern evolutionary theory to the understanding of health and 
disease [54]. The relevance in this case is that the emergence of drug 
resistance is a result of an organism being challenged by a drug because it 
targets an essential element of the cell, and therefore exerts a strong selective 
pressure. As a commensal organism, found on healthy humans and causing 
disease opportunistically, it is not wholly desirable nor realistic to completely 
eradicate C. albicans from an infected host, and failing to do so with 
conventional antifungal drugs introduces the risk of leaving behind a drug 




Drug resistance in pathogens is a growing problem, and leads to deaths of 
critically ill people. Multiple antimicrobial drugs are often employed 
sequentially in a single infection, with treatment being changed in response to 
resistance arising [55]. This raises a multitude of questions for evolutionary 
medicine; for example, whether the resistance evolves in response to the drug 
or whether it is acquired from other organisms; or whether drugs could be 
administered differently to evade resistance pre-emptively. A lack of answers 
to these questions means that changes to treatment are based on guess-work 
and are frequently unsuccessful [55]. 
The principle of evolutionary medicine which this study explored was to identify 
a target for future drug design which would subvert drug resistance, thereby 
increasing the value and longevity of the drug, as well as allowing for a simple 
treatment regimen. 
Taking evolutionary mechanisms into account prior to the development of new 
drugs is prudent; lessons should be learned from the repeated evolution of 
resistance to antimicrobial compounds. This strategy of drug design to evade 
resistance is now being employed for health threats as diverse as cancer [56] 
and malaria [57].  
The change from commensal to virulent growth involves significant changes 
in gene expression in C. albicans [58, 59]. Abrogating virulence rather than 
growth provides a unique opportunity for treatment that would mitigate the 




drug resistance. This would obstruct the ability of C. albicans to continue to 
cause disease, allowing for the host immune system, or a secondary antifungal 
drug administered combinatorially, to clear the infection efficaciously. This 
should in turn make the emergence of resistance less likely to occur and more 
readily lost if acquired; research in Staphylococcus aureus has shown that 
maintaining drug resistance genes is quite costly to the organism and lack 
exposure to the drug results in loss of resistance [60]. Drug resistance is often 
a costly trait and in conditions where drug is absent, drug susceptible strains 
will frequently out-compete the resistant ones [61] so in such conditions it is 
advantageous for drug resistance to be sacrificed. Indeed, by the same 
principle, employing non-essential drug targets may additionally extend the 
usefulness of existing antifungals if they can then be used more sparingly and 
so reduce the spread of resistance. 
In addition, evidence shows that in a hospital setting, bacteria have a tendency 
to repidly lose acquired resistance to antibiotics, even when the resistance 
does not confer a fitness cost [62]. This provides further motivation for 
developing new treatment stategies which employ existing antimicrobial drugs 
sparingly, in order to avoid problems of widespread resistance. 
Evolutionary medicine is a concept yet to be applied to fungal virulence; in the 
quest for novel drug targets to treat candidiasis Hsp90 is conspicuous as a 
regulator of virulence [24, 63]. However, due to its essentiality, Hsp90 does 
not make a suitable drug target for fungal infections, but the Hsp90 co-




to the principles of evolutionary medicine. Whilst most of the co-chaperones 
being investigated in this study are conserved in humans, they share far less 
sequence identity than other proteins, such as Hsp90, and so show some 
potential as more suitable drug targets. 
 
 
1.2 The molecular chaperone Hsp90 regulates virulence traits 
in C. albicans 
 
1.2.1 Hsp90 is essential and highly conserved 
Hsp90 is an essential and well-studied molecular chaperone conserved in all 
known eukaryotes, with orthologues being universally required for viability [64-
66]. In C. albicans, Hsp90 interacts with ~4% of the genome, most of which 
are genes thought to function downstream of Hsp90 as they are not essential 
in all conditions [67]. In C. albicans Hsp90 is a homodimer, which operates in 
a clamp-like structure; closed when adenosine triphosphate (ATP) is bound, 
and open when adenosine diphosphate (ADP) is bound (Fig. 1.2) [68, 69].  
The name of Hsp90; 90 kDa Heat Shock Protein, was inspired by the size of 
its orthologue in Homo sapiens and its discovery in the 1970s as one of a set 




Drosophila melanogaster [26, 70]. Orthologues are present across the 
eukaryotic domain, and Hsp90 was identified in yeast later that same decade 
[71].Although the protein is highly conserved across eukayotes and 
orthologues share the same name, its size does vary slightly; Hsp90 is only 
80.8 kDa in C. albicans [72]. 
 
 
Figure 1.2 [A] Crystal structure of Saccharomyces cerevisiae Hsp90 [73] with 
the amino-terminal domain (N), middle domain (M), and carboxy-terminal 
domain (C) indicated, and [B] a simplified diagram of Hsp90 showing which 
domain the co-chaperones bind to. Aha1 can bind both the middle domain and 




Inhibition of Hsp90, which repairs proteins, leads to widespread protein 
degradation, including proteins responsible for growth. Thus, inhibition of 
Hsp90 has been shown to limit growth of cancer cells [74] inhibitory 
compounds based on geldanamycin have even reached clinical trials as anti-
cancer drugs [75, 76]. 
Geldanamycin and radicicol are common Hsp90 inhibitors which operate by 
binding near the N-terminus of Hsp90, thereby blocking the ATP binding site 
for the protein [77, 78]. Inhibition is specific to the Hsp90 protein as the 
particular amino acid motif is atypical of eukaryotic proteins, being more 
usually found in prokaryotic organisms [79, 80]. 
More recently, a number of similar compounds have been found to inhibit 
growth of cells in liver and colon cancers in vitro, as well as having antifungal 
effects on C. albicans [81-83]. Preliminary results suggest the mode of action 
involves suppressing the expression of a number of genes, including HSP90 
and ERG11, by inhibiting the necessary transcription factors [47, 48, 84]. 
Significantly, overexpression of Erg11 is one of the known azole resistance 
mechanisms [47, 48]; combinatorial therapy with a compound which reduces 
its expression may act to undermine this resistance and allow for successful 
treatment of infections. 
Hsp90 buffers the effects of deleterious mutations to keep cells phenotypically 




and the mutation rate of the cells increases in response, Hsp90 helps to lower 
the associated risks.  
 
1.2.2 In C. albicans, Hsp90 regulates important virulence traits 
Hsp90 is an essential regulator of virulence and morphogenesis, as well as 
being required for cell viability [63, 87]. Due to its high level of conservation 
with the human homologue; 63% sequence identity, Hsp90 is an unsuitable 
drug target [88]. The shared evolutionary history between mammals and fungi 
means that this problem of conservation is common in what would otherwise 
be potential drug targets; inhibiting Hsp90 during systemic candidiasis in a 
murine model of disease resulted in lethal host toxicity [2]. The essentiality of 
Hsp90 means that targeting it would also encourage development of 
resistance, both in the host and in the external environment. 
Hsp90 has been shown to be instrumental in the success of drug resistant 
strains of C. albicans and regulates the response and adaptation of the 
organism to inhibitory compounds [35, 89]. In addition, Hsp90 functions to aid 
dispersal of C. albicans biofilms; a virulence trait which protects cells from 
drugs and the host immune system as well as seeding the infection [63]. 
The function of Hsp90 is dependent upon its working in concert with its 




Hsp90’s activity (Fig. 1.2). Hsp90 is essential to C. albicans but makes a poor 
candidate for a drug target due to its high conservation with the human 
orthologue. The aim of identifying Hsp90 co-chaperones as novel drug targets 
is to indirectly abrogate Hsp90 function and thus undermine C. albicans 
virulence, including drug resistance. 
 
1.2.3 Hsp90 acts in concert with co-chaperones 
The Hsp90 co-chaperone machinery of C. albicans involves 14 co-chaperones 
working in concert with Hsp90; the complex is dynamic with co-chaperones 
variously regulating localisation, activity, and binding specificity of Hsp90 [90-
105]. To date, co-chaperones in C. albicans are understudied and poorly 
understood. 
Hsp90 co-chaperones were selected based on their location in the genome 
(Fig. 1.3). Virulence genes are often found close to the telomeres, with 
examples including the TLO genes in Candida [3] and the VAR genes in 
Plasmodium [4], and even the effector genes in the causative organism of rice 
blast, Magnaporthe [5], which are all groups of genes implicated in virulence. 
Orthologous co-chaperone genes in S. cerevisiae, Candida’s non-pathogenic 
relative, are distributed along the whole length of the chromosome. In the 
pathogenic C. albicans, Hsp90 co-chaperone genes are clustered towards the 




genomic locale suggests that gene expression can be regulated by 
heterochromatin formation to silence genes [106, 107]. 
 
 
Figure 1.3 Diagram of C. albicans chromosomes drawn to scale, labelled with 
their names and sizes on the left, and positions of co-chaperone genes and 
centromeres marked on the chromosomes themselves, with distance to the 
telomere indicated in brackets. Null mutants were generated in this stufy for 
the co-chaperones shown in blue. The Hsp90 co-chaperone genes are 





Previous research showed that depleting the co-chaperone Sgt1 in C. albicans 
reduced resistance to azoles and echinocandins [108], implying promise for 
the rest of the Hsp90 co-chaperones. Yet, Sgt1 is an essential protein and thus 
not fitting for a project employing the principles of evolutionary medicine. 
Conservation of Hsp90 between humans and yeasts is a problem which 
largely precludes its employment as a drug target. Co-chaperones are less 
conserved, although conservation for them remains consistent throughout 
eukaryotes, and evolutionary evidence suggests non-conserved co-
chaperones were selectively lost rather than gained [109]. 
Five co-chaperones were selected for this study to be investigated for their 
roles in C. albicans virulence. All of them were believed to be encoded by non-
essential genes, based on generation of mutants in Saccharomyces 
cerevisiae. The aim here was to identify co-chaperones which are essential 
for virulence, but not required for growth to comply with the principles of 
evolutionary medicine. 
Ssa1 and Ssa2 bind indirectly the C-terminal domain of Hsp90 and are 
considered to be orthologues of the human Hsp70 family of proteins (Fig. 1.3) 
[23, 110]. Sti1 is the mediator which binds both the C-terminal domain of 
Hsp90 and the C-terminal domain of the Hsp70 orthologues; Ssa1 and Ssa2 
[111, 112]. Ssa1 and Ssa2 are relevant to this study because of their 
implication in invasion of host cells [113] and survival of heat shock [114]. 




expression is decreased, so protein translation or protein stability may be 
disassociated from gene expression levels [115]. The two are very similar to 
one another, with 85.8% identity in the gene sequences, and 87.2% similarity 
in their protein sequences [116], which suggests they are alike in structure and 
function.  
The Ssa1 and Ssa2 proteins have been found to be responsible for binding 
the antimicrobial compound in human saliva, histatin 5 and null mutants of 
both genes in Saccharomyces cerevisiae are resistant to its effects [117]. 
However, Ssa1 has also been found to mediate invasion of host cells and is 
therefore instrumental in C. albicans virulence [118]. 
The Sba1 protein has low sequence identity of 23% with the human 
orthologue, p23 [116] and is induced in the stress response to heavy metals, 
and protein levels decline in stationary phase growth [119]. Sba1 may have a 
role in aging as it is implicated in telomere maintenance in C. albicans and S. 
cerevisiae null mutants for SBA1 have been shown to have shorter telomeres 
[72, 120]. Sba1 binds the N-terminal domain of Hsp90 and of the co-
chaperones present in both C. albicans and humans, Sba1 has the lowest 
protein sequence identity [97].  
Aha1; “Activator of Hsp90 ATPase”, acts as its name suggests and induces 
Hsp90 ATPase activity through binding the middle domain and the N-terminal 
domain of Hsp90. Aha1 has 26.7% protein sequence identity with its human 




domain of Hsp90 in C. albicans [116]. Depleting Aha1 results in decreased 
client protein activation, suggesting that Aha1 is responsible for activation, 
rather than stability [121]. Aha1 is known to be induced by oxidative stress and 
by heavy metal stress, and to be expressed at higher levels in biofilms relative 
to planktonic growth in C. albicans [15, 115, 122]. 
The binding sites for Sba1 and Aha1 are overlapping on the N-terminal domain 
of Hsp90, but Aha1 also binds the middle domain [123], so they are not 
mutually exclusive components of the Hsp90 complex [121, 124].  
Sti1 is also differently expressed in biofilms and is 36.5% conserved in protein 
sequence with its human orthologue, Hop1, which is the “Hsp70-Hsp90 
organising protein” [116]. That Sti1 is not essential for viability shows there 
may be alternative mechanisms facilitating interaction between Hsp90 and 
Hsp70 (Ssa1/2). It was recently demonstrated that Hsp90 and Hsp70 do 
indeed interact directly, with Hsp70 binding a region on the middle domain of 
Hsp90 in the absence of Sti1 [125]. Disrupting the protein-protein interaction 
between Hop1 and Hsp90 has shown positive results in reducing growth in 
breast cancer cells [126].   
Tah1 is the only fungal-specific co-chaperone in this group, making it perhaps 
the most desirable co-chaperone for future development as a drug target. C. 
albicans Tah1 is uncharacterised, and its orthologue in S. cerevisiae, Tah18, 
is known to be essential for viability [127]. In S. cerevisiae Tah1 regulates 




nitric oxide production conferring resistance to high temperature stress [129]. 
The potential essentiality of Tah1 in C. albicans would make it an unsuitable 
drug target when adhering to the principles of Evolutionary medicine. 
However, as the only fungal-specific Hsp90 co-chaperone it is desirable to 
ascertain whether this is the case.  
 
 
1.3 C. albicans virulence genes and their regulation 
 
1.3.1 Heterochromatin and sub-telomeric gene silencing 
Regulation of gene expression is required for adaptation to a changeable 
external environment. In eukaryotes, gene expression can be silenced by 
formation of heterochromatin, which makes the DNA inaccessible for 
transcription [130]. DNA in heterochromatin is bound around histones, which 
are the alkaline proteins key to nucleosome structure. When acetylated, 
histones are inactive and DNA is in the more open euchromatin structure, 
allowing for genes to become transcriptionally active [131, 132]. Deacetylation 
activates histones and triggers heterochromatin formation, thus silencing gene 
expression. Levels of histone acetylation vary constantly throughout the cell 




proteins can regulate gene expression by initiating gene silencing in telomeric 
regions of the genome [133].  
Histone deacetylases are known to be involved in all stages of 
heterochromatin formation; in initiation, spreading, and maintenance of 
heterochromatin [134, 135]. Inhibition of histone deacetylase activity has been 
shown to interfere with heterochromatin in S. cerevisiae, thus disrupting 
regulation of gene expression [136]. 
 
1.3.2 Histone deacetylases as regulators of fungal virulence 
The sub-telomeric locale of the co-chaperone genes implicates them in 
virulence because of gene regulation mechanisms in these regions [3, 107]. 
The sirtuins are a group of histone deacetylases responsible for transcriptional 
silencing by managing heterochromatin formation, and therefore regulation of 
gene expression in both humans and fungi [137]. The effects of the sirtuins 
are most potent in the telomeric regions of the chromosomes, implicating their 
function in regulation of virulence. The orthologues of the sirtuins in yeast 
explored in this study are the Hst proteins. This project aimed to develop an 
understanding of how Hst1 and Hst2 are involved in regulation of co-




In Candida albicans the closest orthologue of the human Sirt2 (silent 
information regulator type 2) is Hst1 [116]. C. albicans expresses four sirtuin 
proteins; Sir2, Hst1, Hst2 and Hst3. Sir2 would seem to be the closest 
orthologue to the human Sirt2 based in their names, but is less conserved than 
the Hst proteins. Hst1 and Hst2 were selected for investigation into their role 
in regulating expression of Hsp90 co-chaperone genes in C. albicans. A null 
mutant for Hst3 could not be generated as it is essential for C. albicans viability 
and was therefore not investigated here [138].  
C. albicans has a highly plastic genome, which, as a predominantly clonal 
fungus, helps in introduction of phenotypic variation [139]. There are 
mechanisms acting to maintain stability under normal conditions to suppress 
deleterious mutations [140]. However, mutation rates increase in response to 
environmental stresses as this increases population diversity and drives faster 
rates of evolution and thus adaptation to new environmental conditions [141]. 
Sir2 suppresses recombination activity in plastic sub-telomeric sequences to 
help maintain genome stability when environmental stress levels are low. 
When cells are stressed, this suppression is overridden to allow for a higher 
mutation rate in response [142]. 
Hst1 and Hst2 are non-essential components of the conserved Set3/Hos2 
histone deacetylase complex. Hst1 and Hst2 have been shown to positively 
regulate white-opaque switching in Candida albicans and null mutants have a 
reduced ability to undergo phenotypic switching [143]. C. albicans exhibits a 




are known as white and opaque cells. The two cell types differ in gene 
expression, cell morphology, and colony shape, and opaque cells are able to 
mate, whereas white cells are not. White-opaque switching is a well-studied 
trait of C. albicans, however, the ability to switch is only possessed by cells 
homozygous for the mating-type locus (MTL) and as the majority are 
heterozygous, they are unable to switch. 
Histone deacetylases Hst1 and Hst2 regulate expression of genes in telomeric 
regions by forming heterochromatin to silence genes. They were selected for 
study here to investigate their role in regulation of Hsp90 co-chaperone gene 




1.4 Investigating the roles of Hsp90 co-chaperones in C. 
albicans virulence traits – experimental approaches 
 
 
1.4.1 In vitro assays to study the role of Hsp90 co-chaperones in 
fungal virulence 
Here, the hypothesis is that Hsp90 co-chaperones govern virulence and that 
targeting co-chaperones that are not essential for growth but are required for 
virulence could abrogate Hsp90 function whilst avoiding host toxicity and 
reducing selective pressure for resistance. Applying the principles of 
evolutionary medicine; it is desirable to employ a drug target which inhibits the 
ability of the organism to cause disease, whilst leaving it unaffected in its 
commensal form [54]. This could discourage the emergence of drug 
resistance, making the drug more potent and available as an option for disease 
treatment in the long term, while also carrying the benefit of leaving the host 
microbiome unscathed by the treatment.  
Exploring the potential of Hsp90 co-chaperones as candidates for 
development of novel therapeutic strategies to treat systemic Candida spp. 
infections and employing the principles of evolutionary medicine was the main 
aim of this project. Non-essential Hsp90 co-chaperones that regulate C. 




albicans Hsp90 co-chaperones are largely uncharacterised; little is known 
about their essentiality and even less about their roles in regulating virulence. 
Homozygous null mutant strains for co-chaperone genes were generated from 
the SN95 background strain [144], referred to here as YSD89. The strain was 
originally a clinical isolate, SC5314 [145], but has been genetically modified to 
be auxotrophic for histidine and arginine, which is not the natural case in C. 
albicans. The auxotrophies are conferred by homozygous gene deletion of 
HIS1 and ARG4.  
Once two independent deletion mutants of the SSA1, SSA2, SBA1, AHA1, 
and STI1 genes were generated, they were assessed for an essential role in 
four standard growth conditions. These were in rich media and in synthetic 
defined media at both 30°C and at the physiologically relevant temperature of 
37°C. It is important to determine that targeting co-chaperones will not confer 
a growth defect, making the yeasts less competitive in the environment. The 
aim was to target cellular aspects that are only required in a virulence setting 
and will therefore abrogate their capacity to cause disease without impairing 
commensal populations. 
Whilst growth in these two media formulations at the two temperatures would 
not necessarily be a true and accurate reflection of how the yeasts would grow 
in their natural environmental conditions, it can be used as an indication of 





The impact of co-chaperones on C. albicans virulence was then quantified by 
comparing mutant strains to the wild type in a set of virulence assays. There 
were five in vitro virulence assays; resistance to oxidative stress, heat shock 
tolerance, drug resistance, morphogenesis, and biofilm formation.  
 
1.4.2 A novel host model of infection 
Manduca sexta are established as a model organism for in vivo testing of 
pesticides and bacterial infections [146-148], but the animals have never 
previously been used as a model for fungal infections. Work in the Diezmann 
laboratory has optimised their use for fungal infection studies. In accordance 
with principles of the NC3R [149], this could replace the use of vertebrates 
such as mice in some studies, thus reducing the number of mice used in 
laboratory experiments. 
The University of Bath has been hosting a resident colony since 1978. This 
inbreeding colony is maintained by a dedicated technician who follows 
standard procedure in proliferating animals and preparing them for 
experiments. Due to their size and weight, M. sexta fifth instar larvae can be 
injected with a defined number of yeast cells. Larvae thrive at 37C, which is 
physiologically relevant when carrying out studies of human pathogens. The 
M. sexta genome has recently been published [150], allowing future 




In this study, M. sexta fifth instar larvae were infected with C. albicans co-
chaperone mutants and the wild type strain. Virulence assays were controlled 
with saline. All animals were screened daily for death, and morbidity was 
quantified by measuring changes in body weight.  
 
1.4.3 Regulation of co-chaperone genes 
Expression of genes in telomeric regions is partly regulated by 
heterochromatin formation to induce silencing. The roles of histone 
deacetylases Hst1 and Hst2 on expression of Hsp90 co-chaperones was 
measured by quantitative real-time polymerase chain reaction (qRT-PCR). 
Expression of the five co-chaperones of interest was compared between the 





Systemic candidiasis is a public health problem of growing importance due to 
limited treatment options and the spread of resistance to existing antifungal 
drugs.  
Taking into account the evolutionary mechanisms involved in the emergence 
of resistance in response to the selective pressure exerted by fungicidal drugs, 
as well as the simplicity of targeting a pathogen with only one compound. This 
study aims to identify at least one potential drug target, required for virulence 
characteristics but not essential for viability in commensal growth, which could 
be employed for intelligent drug design. Targeting a component of the 
pathogen exclusive to virulence could subvert the spread of drug resistance. 
Such a drug would be intended for use in combinatorial therapy, perhaps with 
an Hsp90 inhibitor, posing an additional challenge to the pathogen and further 
discouraging the evolution of resistance. Results presented here demonstrate 
that Hsp90 co-chaperone mutants exhibit comparable growth to the wild type 





2. Materials and Methods 
 
 
2.1 Strain Construction 
 
Homozygous null mutants were generated for the genes of interest in order to 
confirm non-essentiality and to investigate their function. Strains were 
constructed by homologous recombination of a recyclable drug marker 
encoding resistance to nourseothricin (NAT) (a gift from Julia Köhler) using the 
lithium acetate protocol (Appx. 8.1) [151-153]. The NAT cassette is encoded 
on plasmid pSD3, which additionally encodes a FLP recombinase excision 
gene, expressed by metabolism of maltose. The cassette is then easily 
excised, resulting in a clean gene deletion. The NAT cassette was amplified 
with Q5 High-Fidelity DNA polymerase and 120-mer primers (Appx. 8.3). 
Primers correspond to 100 bp upstream and downstream flanking regions of 
the gene, with 20 bp oligonucleotides homologous to the plasmid encoding the 
NAT cassette. This reaction generated copies of the NAT cassette with 100-
mer flanking regions homologous to the gene of interest. A total of at least 100 
µL PCR product was generated for each transformation reaction. The protocol 
is optimised for XmnI-digested pSD3 plasmid (Table 2.1). Gene sequences 
were accessed on candidagenome.org and primers were designed using 
primer3.ut.ee to identify suitable sequences. Potential primers were searched 




sequences in the C. albicans genome. The reference genome applied was 
assembly 22 [154]. 
 
 
For some genes; SBA1, AHA1, and STI1, the same 100mer flanking regions 
were amplified for transformation of both allele deletions. Whereas for others; 
SSA1, SSA2, HST1 and HST2, a third long primer was used, located outside 
of the rest, to improve transformation efficiency in removal of the second allele 
(Fig. 2.2). The result was that one of the long sequences of homology for the 
second allele deletion was no longer present, precluding the NAT cassette 
from transforming back into the empty locus and thus improving transformation 
Figure 2.1 Gene deletion strategy using 
the recyclable NAT cassette. The NAT 
cassette was amplified from XmnI-
digested pSD3 by Q5 PCR using 120-
mer primers complementary to the 
flanking regions of the gene, SSA1 in this 
example, with an oligonucleotide region 
complementary to the NAT cassette. As 
C. albicans is an obligate diploid, two 
rounds of transformation are required to 
delete both alleles of the wild type gene. 
The NAT cassette is flipped out following 
each successful transformation reaction, 
as confirmed by colony PCR, resulting in 
a complete deletion of both alleles of the 




efficiency. Sequences were checked in design of the third long primer to avoid 






Figure 2.2 A. For some genes, the first allele was transformed using a third 
long primer further from the native gene, shown in orange. B. For other genes, 




Successful PCR products, identified by agarose gel electrophoresis, were then 
purified by ethanol precipitation. To do so, 100 µL PCR product was combined 
in one 1.5 mL Eppendorf tube. A volume of 10 µL sodium acetate pH 5.2 was 




ethanol was added and the tube was inverted 5 times to mix and the product 
was incubated at -20˚C for 30 minutes before being centrifuged at maximum 
speed for 10 minutes at room temperature. The supernatant was removed and 
the pellet washed with 70% ethanol. The tube was blotted dry on paper and 
centrifuged for 30 seconds before the remaining liquid was removed. The 
pellet was air-dried for 20 minutes to ensure total ethanol evaporation and 





Table 2.1 PCR reagents and programme for NAT cassette amplification; 
recipe for one 50 µL reaction. 
 
PCR REAGENT VOLUME (µL) PCR PROGRAMME 
Water 36.1 98°C 2 min 
5x buffer 10 98°C 30 s 
55°C 30 s       30 cycles          
72°C 3:30 m 
25 mM dNTPs 0.4 
100 µM primer (each) 0.25 
0.1 ng µL-1 pSD3 2 72°C 2 min 






To determine purity and concentration of the DNA used for the transformation 
reaction, the purified PCR product was run on 1% agarose gel dissolved in 1x 
TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA), mixed with SYBR 
Safe® 10,000x dye. The DNA was separated at 100 V. All PCR products were 
screened under these conditions prior to use. 
 
In preparation for DNA transformation, C. albicans strains were cultured for 16 
hours in 10 mL YPD (2% yeast, 1% peptone, 2% dextrose) to a target OD600 
reading of between 4 and 8. To attain this level of growth, a 1 µL sterile 
inoculation loop was used to collect a small pellet of cells from a YPD-agar 
plate to inoculate 10 mL broth. This was then diluted to 1:200 in a fresh tube 
of broth before incubation at 30°C with 200 rpm orbital shaking. For deleting 
the first allele of the gene, the wild type strain YSD89 would be transformed. 
The overnight cultures were diluted 1:10 in water and the OD600 was 
measured. Cultures ranging between OD600 4-8 were then used for 
transformation. The following formula was employed to standardise the 
number of yeast cells in each reaction: 
 
10/(OD600*1.5) = mL culture per transformation reaction  
 
Cells were washed once with 1mL sterile water and centrifuged for 7 seconds. 
A volume of 800 µL sterile filtered 50% polyethylene glycol (PEG) 3350 was 
added to the tube, followed by 260 µL transformation master mix and 50 µL 




µL 10x TE, 100 µL 1 M lithium acetate pH 7.4, 40 µL 5 mg mL-1 salmon sperm 
DNA (boiled for 5 minutes and kept on ice), and 20 µL 1 M DTT (dithiothreitol). 
 
Each transformation reaction was incubated in a water bath at 30˚C for 1 hour, 
before being transferred carefully to 42˚C for 45 minutes; this time was 
reduced to 30 minutes if the strain was known to be heat-sensitive. The cells 
were then centrifuged for 8 seconds and the transformation mix was removed. 
As the NAT cassette needs to be expressed prior to exposure to the drug in 
order to confer resistance, cells were incubated for 4-6 hours in 600 µL YPD 
at 30˚C 200 rpm, before being plated onto YPD plates containing 
nourseothricin at a final concentration of 150 µg mL-1, (YPD-NAT). The whole 
600 µL volume was plated out and spread as gently as possible. The plates 
were left to dry before being incubated at 30˚C for three days, when colonies 
were re-streaked onto fresh YPD-NAT plates. 
 
 
Table 2.2 PCR reagents and programme for colony genotyping. 
 
PCR REAGENT VOLUME (µL) PCR PROGRAMME 
2x master mix 7.5 94°C 5 m 
100 µM Primer (each) 0.1 94°C 30 s 
53°C 45 s      30 cycles 
72°C 1 m 
Water 7.3 
Colony cells n/a 




Presence of the NAT cassette is detected as well as integration into the proper 
location by colony PCR (Table 2.2). After deletion of the first allele, potential 
positive transformants were tested for the presence of the NAT cassette. Cells 
were sampled directly from the transformation plate into the PCR mix. A 
section of the flanking yeast DNA, overlapping into the NAT cassette was 
amplified, both upstream and downstream of the integrated drug marker. This 
involved two separate reactions for each colony to detect correct up- and 
downstream integration (Appx. 8.3). Primers were designed to produce an 
expected PCR product of ~500 bp in each case. 
 
Once a yeast colony had been identified containing the NAT cassette in the 
appropriate location, the NAT marker was excised. Expression of the excision 
gene on the NAT cassette is induced by growth in yeast nitrogen base, with 
bovine serum albumin and maltose (YNB-BSA-MAL). Cells from the NATR 
colony were inoculated into 5 mL YNB-BSA-MAL and incubated for 2 days at 
30˚C while shaking at 200 rpm. This culture was then diluted 1:10,000 in YPD 
broth and a further 1.6 µL was diluted into 200 µL YPD broth. Of this, 150 µL 
was plated onto YPD agar and incubated for two days at 30˚C. After 
incubation, the plate was replicated onto both YPD and YPD + 150 µg mL-1 
NAT agar plates, which were then incubated for two days at 30˚C. Comparison 
between the two replica plates was then used to identify NATS colonies. 
 
Following excision of the NAT cassette, it was possible to repeat this method 
using the same transformation marker for deletion of the second allele. 




8.3), involving amplification of ~500 bp of the wild type gene and screening for 
a negative result. Cells of the wild type strain, YSD89, were used as a positive 
control for this reaction. Colonies found to be lacking the wild type allele were 
then tested for upstream and downstream integration of the NAT cassette, as 
above. Once successful deletion of both wild type alleles was ascertained, the 
NAT cassette was once again excised by growth in YNB-BSA-MAL and the 
gene deletion was complete and the strain prepared for archiving at -80˚C. 
 
In preparation for cryogenic storage, gene deletion mutants were grown 
overnight in YPD at 30˚C with 200 rpm. The resulting culture was diluted 1:1 
in 50% glycerol, giving a final concentration of 25% glycerol, and frozen at -
80˚C. Ideally, two independent transformants were generated for each 
mutation. Two NATS colonies were frozen down for each positive transformant, 
as well as the NATR transformant still containing the NAT cassette but with the 





2.2 Co-chaperone Mutant Characterisation 
 
 
2.2.1 Growth Curve Analysis 
 
Characterising the mutants first involved comparing their growth to that of the 
wild type strain YSD89 to assess whether mutants had growth defects. Two 
independent transformants for each gene deletion were tested in a 96-well 
plate-reader assay in four different conditions; enriched media (YPD) and 
synthetic defined media (yeast nitrogen base, 2% glucose) at 30˚C and at 
37˚C. Strains were grown overnight in the relevant media at 30˚C with 200 rpm 
orbital shaking for 12-16 hours, cultures were then diluted 1:50 in water and 
the OD600 measured. The OD600 was adjusted to 0.05 in fresh media and 96-
well plates inoculated; 8 wells were inoculated for each strain as technical 
replicates and cultures were measured at OD595 every 30 minutes throughout 
the 24-hour assay. Three biological replicates were carried out for each 
condition. Data were analysed in R 3.4.1 GUI 1.70 El Capitan build® using the 
Growthcurver package to obtain and compare growth metrics by ANOVA; 










2.3  In vitro Virulence Assays 
 
 
2.3.1 Oxidative Stress Resistance 
 
The oxidative stress resistance assay is used to assess whether mutant 
strains are impaired in their ability to resist the stress induced by the oxidative 
burst mechanism of the host innate immune system. Cells were grown 
overnight in YPD at 30˚C with 200 rpm orbital shaking for 12-16 hours and 
their OD600 measured. The culture was adjusted to OD600 0.2 in 10 mL YPD 
broth and cells were incubated for 3 hours at 30˚C with 200 rpm orbital 
shaking, until they proliferated to reach OD600 between 0.6-0.8, indicative of 
mid-log phase growth. Using the OD600 value and data from a previously 
plotted standard curve (data not shown), each strain was diluted to 20,000 cfu 
mL-1 in 1x phosphate-buffered saline (PBS) and divided into 2 tubes of 5 mL 
each. A dilution of 1:10 was made of this inoculum and 100 µL plated onto 
YPD agar to demonstrate pre-treatment colony growth.  
 
A final concentration of 1 mM hydrogen peroxide was added to one 5 mL 
culture of each strain, with the second tube serving as no-treatment control. 
Concentration of hydrogen peroxide was determined by measurements of 
OD240 in quartz cuvette and solving the Beer-Lambert equation with a molar 





Tubes were incubated at 37˚C with 200 rpm orbital shaking for 1 hour. The 
cultures were diluted 1:10 in 1x PBS before 100 µL was plated onto YPD agar 
with 5 technical replicates and incubated at 30˚C for 2 days. Colonies were 
counted to measure the percentage survival of cells exposed to hydrogen 
peroxide compared to the untreated controls. This experiment was repeated 
for a total of 3 biological replicates for each mutant strain and data were 
analysed in R 3.4.1 GUI 1.70 El Capitan build® using a mixed linear model 
and plotted as univariate scatter plots. The univariate scatter plots display 
every data point measured, as well as the mean and standard deviation 
values. The mixed linear model compares the rate of survival of the wild type 
strain; the ratio of cfu with to without exposure to hydrogen peroxide, to the 
rate of survival of each other strain. Effectively, fold change is compared, with 




2.3.2 Heat Shock Tolerance 
 
The heat shock tolerance assay measures the ability of C. albicans strains to 
adapt to conditions in the host, particularly when the host exhibits fever as a 
result of the infection. Cells were grown overnight in YPD at 30˚C with 200 rpm 
orbital shaking for 12-16 hours and their OD600 measured. A tetOff-
HSP90/hsp90Δ mutant was used as the negative control strain in this 
experiment as it has been shown to be impaired in its response to heat shock; 




[24, 156]. However, this strain grows more slowly than the other strains 
assayed, and so was grown in YPD enriched with nutrient broth to keep the 
growth rate consistent. The cultures were adjusted to OD600 0.2 in 10 mL YPD 
broth and cells were incubated for 3 hours, until they proliferated to reach 
OD600 between 0.6-0.8, indicative of mid-log phase growth. For this step, 20 
µg mL-1 doxycycline was added to the negative control strain tetO-
HSP90/hsp90Δ to deplete Hsp90 levels. Meanwhile, YPD broth was warmed 
to 54˚C in a water bath and 100 mL conical flasks were warmed to 42˚C in an 
incubator.  
 
Prior to heat shock, cultures were diluted to 10-4 in 1x PBS and 100 µL was 
plated onto YPD agar with 5 technical replicates. The 10 mL culture was then 
mixed with 10 mL of the pre-heated YPD broth in 100 mL conical flasks to 
induce heat shock and incubated at 42˚C for 2 hours with 200 rpm orbital 
shaking. For the negative control strain, 20 µg mL-1 doxycycline was again 
added to the pre-heated broth to maintain repression of HSP90. 
 
The cultures were then diluted to 10-4 in sterile 1x PBS and 200 µL was plated 
onto YPD agar with 5 technical replicates and incubated at 30˚C for 2 days. 
Colonies were counted to measure the growth success of cells exposed to 
heat shock compared to the cultures plated before treatment. This experiment 
was repeated for a total of 3 biological replicates for each mutant strain and 
data were analysed in R 3.4.1 GUI 1.70 El Capitan build® using a mixed linear 
model and plotted as univariate scatter plots. The univariate scatter plots 




deviation values. The mixed linear model compares the rate of growth of the 
wild type strain; the ratio of cfu before to after subjection to heat shock, to the 
rate of growth of each other strain. Effectively, fold change is compared, with 




2.3.3 Colony Morphology on Solid Growth Media 
 
Colony morphology of the different strains was compared on 6 different solid 
media formulations; YPD agar, Spider agar, RPMI agar, Sabouraud dextrose 
(SD) agar with Calcofluor White, SD agar with Congo Red, and Lee’s medium 
(Appx. 8.4). Agar was poured into rectangular omniplates and inoculated using 
liquid cultures grown in YPD in 96-well plates in a defined layout. A 96-well 
microplate replicator was used to inoculate the agar plates and replicate the 
layout from the 96-well plates. The replicator was washed twice with water and 
ethanol and sterilised by flaming following each inoculation.  
 
Inoculated plates were incubated inverted and static at 37°C for 5 days, while 
wrapped in aluminium foil to minimise desiccation. Colony morphology was 
scored according to appearance on the plates (Table 2.3) and compared 







Table 2.3 Colony morphology scoring scheme. 
 
MEDIUM MORPHOLOGY SCORES 
YPD 1. Punctiform colonies 
2. Less vigorous growth 
3. Butyrous, entire colonies 
Spider 1. Glabrous colonies, little or no halo 
2. Glabrous centre with filiform halo 
3. Wrinkled centre with filiform halo 
4. Robust wrinkles, little or no halo 
RPMI 1. Dry, rough, entire colonies 
2. Dry, rough, semi-filiform colonies 
3. Dry, rough, filiform colonies 
SD + Calcofluor White 1. Glabrous, entire colonies 
2. Rough, entire colonies 
3. Wrinkly, undulate colonies 
4. Robust wrinkles on undulate colonies 
SD + Congo Red 1. Glabrous centre with wrinkled halo 
2. Wrinkled centre and halo 
3. Large, undulate colonies with robust 
wrinkles 
Lee’s 1. Dry, entire colonies with robust wrinkles 





2.3.4 Biofilm Formation 
 
Biofilm formation is a potent virulence trait, which affords invasive cell 
communities protection from drugs and the host immune response, as well as 
providing a reservoir of cells to seed the infection. Biofilm formation was 
quantified using the XTT assay, which measures biofilm metabolic activity 
[157].  
 
For the assay, flat-bottomed 96-well plates were primed with 100 µL bovine 
serum in each experimental well, with 200 µL 1x PBS pipetted into outermost 
wells to maintain humidity. The plates were then incubated at 37˚C static 
overnight. Meanwhile C. albicans strains were inoculated into 10 mL YPD and 
incubated at 30˚C with 200 rpm orbital shaking for 12-16 hours.  
 
On the second day, the yeast cultures were adjusted to OD600 0.5 in Roswell 
Park Memorial Institute medium (RPMI) 1640 broth (2% maltose, 2% glucose) 
pH7. The 96-well plate experimental wells were washed once with sterile 1x 
PBS and filled with 100 µL of the adjusted cultures, with 8 technical replicates 
of each. Following adhesion at 37˚C static for 90 minutes, the cell suspension 
was removed by vacuum suction and replaced with fresh RMPI broth. The 
plates were incubated for 24 hours static at 37˚C, after which mature biofilms 
were washed 3 times with sterile 1x PBS.  
 
Solutions of XTT and menadione for addition after incubation were prepared 




Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) was diluted to a final 
concentration of 0.5 mg mL-1 in 1x PBS and centrifuged at 3000 rpm for 5 
minutes. The supernatant was stored -20°C in 10 mL aliquots. One aliquot was 
thawed without light exposure for each 96-well plate and 5 µL 10 mM 
menadione was added immediately before use. Menadione was diluted in 
ethanol and stored at -80°C in 1 mL aliquots in amber tubes to avoid light 
exposure.  
 
Of the XTT menadione solution, 100 µL was added to each experimental well 
and plates incubated for 5 minutes at 37˚C static. Finally, each well was 
measured at OD492 and compared to the wild type YSD89 and the negative 
control strain bcr1Δ/Δ [158]. This experiment was repeated for a total of 3 
biological replicates for each mutant strain. The values were plotted as 
univariate dotplots and compared in R 3.4.1 GUI 1.70 El Capitan build® using 
a mixed linear model and ANOVA. The mixed linear model in this case 
compared the spread of the values for the wild type with the spread for each 
other strain. Pairwise comparisons were also conducted to measure 








2.3.5 Antifungal Drug Resistance 
 
Antifungal drug resistance is a growing problem for treatment of systemic 
fungal infections, and Hsp90 function is considered to be instrumental in 
conferring this trait [24, 35]. Growth in the presence of fluconazole (FL) at a 
range of concentrations was measured by optical density in a 96-well plate 
assay to determine the minimum inhibitory concentration. Cultures were grown 
overnight in 10 mL YPD broth at 30˚C with 200 rpm orbital shaking for 12-16 
hours. Cultures were then adjusted to OD600 0.2 in 5 mL YPD broth for the 
plate inoculum. Each well was filled with 100 µL YPD broth, except for the 
right-hand column of wells, in which 180 µL was dispensed. To the 8 wells in 
the right-hand column, 20 µL fluconazole at a final concentration of 5.12 mg 
mL-1 was added and mixed. From these wells 100 µL of YPD broth with 
fluconazole was added to the wells in column 11, and so on to serially dilute 
the drug 1:2 in columns 2-12. The remaining 100 µL of media was then 
discarded and the wells in column 1 kept drug-free as a positive growth control. 
This left the wells with a range of concentrations of fluconazole in YPD from 0 
µg mL-1 to 256 µg mL-1. Inocula were dispensed as follows: 100 µL in each 
well, with each well in duplicate and the plate was incubated 30˚C static for 48 
hours, after which the plate was mixed horizontally and the OD600 was 
measured.  
 
The aim of this experiment was to assess the effect of Hsp90 inhibition on 




inhibitors. The assay was carried out with fluconazole alone, with 5 µM 
geldanamycin in each well in addition to the fluconazole gradient, and again 
with 5 µM radicicol as well as fluconazole.  
 
Data were normalised for each strain so that the well with no drug was given 
a growth value of 1. The data were visualised as heat maps using Java 





2.3.6 Hyphal Morphogenesis 
 
The change in phenotype from yeast to hyphal growth is intrinsic to systemic 
C. albicans infections. Hyphal formation was induced and quantified using 
Frank Odds’ morphology index [159]. Cells were grown overnight in 10 mL 
YPD broth at 30˚C with 200 rpm orbital shaking for 12-16 hours. Cultures were 
then adjusted to OD600 0.2 and incubated with shaking for a further 3 hours, 
until they reached OD600 0.6-0.8. Bovine serum was then added to the cultures 
to a final concentration of 10% v/v and tubes were incubated once more at, 
this time at 37˚C with 200 rpm orbital shaking for 90 minutes. Cells were then 
pipetted onto slides and imaged using a Nikon i90 microscope. Images were 
captured using NIS Elements® imaging software from multiple fields of view 
at 40x magnification. For each strain, 100 daughter cells were selected at 




were taken of the width of the septum, the width of the hypha at the widest 
point, and the full length of the hypha. Morphology index values were 
determined using the formula [159]: 
 
Length * Septum / Maximum diameter2 = Morphology index value 
 
These values were plotted as boxplots and compared in R 3.4.1 GUI 1.70 El 
Capitan build® using a mixed linear model and ANOVA. The mixed linear 
model in this case compared the spread of the values for the wild type with the 





2.4 In vivo Virulence Assays using Manduca sexta larvae 
 
 
Manduca sexta fifth instar larvae were employed as a fungal infection model 
for measurement of the capacity of strains to cause disease and kill an 
invertebrate host [160]. The animals are grown as part of the University of Bath 
research colony, which has been established and inbreeding since the 1980s, 
meaning that the individuals are almost genetically identical. This work is 
covered under Defra licence number 53020/198973.  
 
Figure 2.3 The life cycle of Manduca sexta [161] annotated with key points in 




Animals were infected 13 days after hatching (Fig. 2.3) and fed on solid cakes 
containing a mix of nutrients, agar, and antimicrobial additives (Appx. 8.5). For 
3 days prior to infection the animals were placed on formaldehyde-free food, 
to ensure absence of antifungals in their system. 
 
Yeast cells were washed 3 times in sterile 1x PBS and quantified by 
haemocytometer counting. Cell number was adjusted to 107 cells mL-1 in 1x 
PBS and the cell suspension injected into the rear right proleg of the 
caterpillars. BD Microlance™ 0.3 mm * 13 mm needles, and Terumo™ 1 mL 
syringes were used for injection. The dose was 100 µL of cell suspension, 
equating to 106 yeast cells per animal. Injections of 1x PBS only were 
administered to the control animals.  
 
The caterpillars were then incubated at the physiologically relevant 
temperature of 37˚C for 4 days and screened every 24h for dead individuals 
and weight of surviving animals. Death was plotted in Kaplan-Meier and 
weights were plotted in R 3.4.1 GUI 1.70 El Capitan build® as univariate 
scatter plots. Data were analysed using the Kaplan-Meier estimator and 














Expression of co-chaperone genes of cells in log-phase growth was measured 
in homozygous null mutants for histone deacetylase genes HST1 and HST2 
as well as in wild type strain YSD89 using quantitative real-time polymerase 
chain reactions (qRT-PCR). 
 
Cells were prepared for RNA extraction by overnight growth in YPD at 30°C 
with 200 rpm orbital shaking, before being adjusted to OD600 0.2 and incubated 
again until they reached mid-log growth; OD600 0.6-0.8. The concentration of 
cells in the culture was then calculated and 5*107 cells were harvested, 
washed in sterile distilled water, and pellets were frozen at -80°C overnight.  
 
RNA was extracted using the Qiagen RNeasy mini kit including DNase 
digestion. Following extraction, RNA quantity and purity was determined by 
A260/A280 readings and then used to synthesise cDNA using the Agilent 
AffinityScript cDNA synthesis kit. A quantity of 250 ng-300 ng RNA was used 
per cDNA synthesis reaction, depending on yield from extraction. All samples 
were diluted to the same RNA concentration prior to cDNA synthesis.  
 
The resulting cDNA was used for qRT-PCR (Table 2.5, Appx. 8.6). Double-




Green dye per reaction. The housekeeping gene GPD1 was employed as the 
calibrator. 
 




Data were analysed in R 3.4.1 GUI 1.70 El Capitan build® by ΔCT to compare 
co-chaperone gene expression in mutant strains and the wild type strain [164].  
 
  
PCR REAGENT VOLUME (µL) PCR PROGRAMME 
2x SYBR Green Fast 10 95°C 20 sec 
Fwd primer 10 µM 0.4 95°C 3 sec 
60°C 30 sec       
Melt curve 
Rev primer 10 µM 0.4 
Water 5.2 





3. Generation of homozygous null mutants for 





3.1 Strain construction 
 
Homozygous gene deletion mutants for Hsp90 co-chaperones were generated 
from the wild type strain, YSD89 [144], in order to ascertain that they were not 
essential for viability and to elucidate the roles of those genes in virulence. 
Using the lithium acetate method [151] coupled with the recyclable 
nourseothricin (NAT) cassette [153] allowed for the drug resistance marker to 
be excised by FLP expression [152]; resulting in complete allele deletion and 
allowing for the marker to be used again. Having a recyclable marker was 
particularly useful in this case as C. albicans is an obligate diploid and so each 










3.1.1 Successful deletion of five co-chaperone genes yielding strains for 
further characterisation 
 
Following PCR amplification of the NAT cassette from plasmid pSD3 (a kind 
gift from Julia Köhler), agarose gel electrophoresis was used to confirm 
amplification and purity of the cassette, which reliably produced a single bright 
band. For all transformations, the NAT cassette was amplified with 100 bp 
flanking regions complementary to the native DNA (Appx. 8.3). The sample of 
amplified cassette was always run alongside a negative control, with no DNA 
added, to additionally ensure there was no contamination of other genetic 
material in the reagents. The remaining PCR product of approximately 100 µL 
was used for the transformation reaction. 
 
Upon completion of the transformation reaction, cells suspensions were 
spread onto selective media, containing 150 µg mL-1 nourseothricin. This 
means that only nourseothricin resistant colonies were able to grow on the 
plates, but does not screen for integration site of the cassette. Colonies 
resistant to nourseothricin were tested for correct integration of the NAT 
cassette by colony PCR.  
 
Colony PCR was used to screen the site of integration of the NAT cassette, 
both upstream and downstream following the first round of transformation, 
when the first wild type allele was deleted (Fig. 3.1, Fig. 3.3, Appx. 8.3). 
Unfortunately, this meant that there was no positive control reaction, but a 






Figure 3.1 Diagram showing sites screened for correct integration of the NAT 
cassette [A and B] and for absence of the wild type allele [C]. Correct 
integration of the NAT cassette was ascertained by amplification of ~500 bp of 
the junction where the ends of the insert meet the native DNA, shown in 
orange and green. This was used in both rounds of transformation. 
Amplification of a ~500 bp fragment in the middle of the gene to ascertain 
absence of the wild type allele was used only after the second round of 
transformation; absence of amplification indicated success, shown in red. 
SSA1 is used as an example of a native gene here, but the same method was 
used for screening of all gene deletions. 
 
 
After the second round of transformation, it was hoped that both alleles of the 
wild type gene would have been deleted. However, as well as this being quite 
a low-efficiency reaction, it was possible in some cases for the NAT cassette 
to reintegrate at the site of the first allele. This would leave the remaining wild 
type allele intact in the genome, so absence of the wild type allele was also 
screened for by colony PCR (Fig. 3.1, Fig. 3.3, Fig. 3.4, Appx. 8.3). In this 
case, the wild type strain was used in a positive control reaction, and a reaction 







a positive control for these reactions when screening for negative results. 
Absence of wild type colony PCR was always repeated to confirm the result 




Figure 3.2 Diagram showing identification of nourseothricin-sensitive colonies 
following “flipping”. When colonies are replicated onto YPD and YPD+NAT in 
parallel, colonies which grow only in the absence of nourseothricin are 
sensitive to the drug and have therefore successfully excised the drug 
selectable marker. Nourseothricin-sensitive colonies are circled in red. 
 
 
The use of a third long primer in first allelic deletions of SSA1 and SSA2 
precluded reintegration of the NAT cassette at the site of the empty locus in 
the subsequent round of transformation (Fig. 3.3). Each round of gene deletion 
was followed by “flipping” out of the NAT cassette to complete the homozygous 















































































Figure 3.3 Locations of primers used for transformation and genotyping shown 


















































Figure 3.3 Locations of primers used for transformation shown within native 
gene sequences. Each character denotes a base pair, with colour coding: 
genes (), start codons (), primers of 100-mer flanking regions used for 
transformation (), with the third long primer used in first allele deletion for 
SSA1 and SSA2 (). Short primers were used in genotyping to confirm correct 
integration of the NAT cassette (), and to verify absence of the wild type allele 




Once successful integration of the NAT cassette at the appropriate site in the 
genome had been established, the cassette was excised by expression of the 
flippase (FLP) enzyme encoded on it. Expression of this was induced by 
growing the cells in YNB-BSA-MAL. The cultures were then diluted 10-7 and 
plated onto non-selective YPD agar to grow individual colonies, which in turn 
were replica plated onto selective and non-media for growth comparison (Fig. 





Figure 3.4 Agarose gel showing absence of wild type alleles in homozygous 
null mutants for SSA1 and SSA2 genes, including positive and negative 








Figure 3.4 Agarose gels showing absence of wild type alleles in homozygous 
null mutants for SBA1, AHA1, and STI1 genes, including positive and negative 
controls and 1 kb ladder. Bands show a fragment of the native gene’s DNA in 
the positive controle lanes, which is absent from the mutant strains and from 






Once successfully transformed and “flipped”, mutant strains were grown 
overnight in YPD broth and added to the YSD strain collection at -80C in a 
final concentration of 25% glycerol.  
 
The only fungal-specific Hsp90 co-chaperone gene, TAH1, could not be 
deleted in this study as screening of >600 colonies showed the wild type allele 
still present after attempted deletion of both alleles. It is not yet known whether 
Tah1 is essential in C. albicans, though its orthologue, Tah18, is known to be 
required for viability in S. cerevisiae [127]. A third long primer was used for the 
first allelic deletion of TAH1, so reintegration of the NAT cassette at the site of 
the empty locus can be ruled out (Appx. 8.3). 
 
Additionally, due to the 87.2% protein sequence identity between the Hsp70 
orthologues Ssa1 and Ssa2, generation of a double homozygous null mutant 
was attempted [116]. This was unsuccessful, which may indicate that at least 
one Hsp70 orthologue is required for viability. 
 
 
3.2 Selected co-chaperone genes are not essential for viability 
 
Growth assays provide additional detail about the viability of mutants following 
gene deletion. Generation of homozygous null mutants demonstrates that the 
gene is not essential for viability, as this would preclude null mutant 
generation; but growth assays show whether mutants grow with the same 




rate, and minimum generation time was compared between mutants and the 
wild type strain (Fig. 3.6). 
 
All mutants display comparable growth to the wild type strain, YSD89 (Fig. 
3.5). To account for variation between assays, the wild type strain was 
included in every replicate. The error bars show standard deviation from eight 
technical replicates and are usually larger at the beginning of the assay before 
readings stabilise into a consistent pattern. As growth is exponential, log 
optical density values are plotted on the y-axes. 
 
The ssa1∆/∆ mutants, YSD661 and YSD662, generated curves which follow 
the wild type very closely. The only exception to this is YSD662 in YNB at 
37C, which had a slightly shorter lag phase than the wild type and thus enters 
the exponential growth phase slightly earlier, but thereafter their respective 
growth rates and carrying capacities look almost identical.  
 
The ssa2∆/∆ mutants, YSD702 and YSD731, both have a slightly shorter lag 
phase in YNB at 37C than the wild type, whilst exhibiting very little variation 
in the other three conditions. Following the lag phase both strains grow at 
around the same rate and to the same carrying capacity as the wild type. The 
same is also the case for the sba1∆/∆ mutants, YSD813 and YSD816 and the 
aha1∆/∆ mutants, YSD868 and YSD871. 
 
The sti1∆/∆ mutants, YSD874 and YSD947, again show an almost identical 




the wild type in all but one condition. The exception is in YNB at 37C, when 
the curve for YDS874 is slightly ahead of that of the wild type. YSD947 also 
lags very slightly behind the wild type in both YPD conditions, and exhibits very 
large error bars in YNB at 37C. 
 
Comparing the growth metrics obtained as a proportion of the metric values 
for the wild type strain in each replicate revealed negligible variation between 
strains (Fig 3.4, appx. 8.7). All metrics are presented as unit-less proportions 
rather than absolute values to allow for easier comparisons to the wild type 
strain and to account for assay variation. The K metric denotes the carrying 
capacity, or the highest OD600 reading the culture reached during the 24-hour 
growth period as a proportion the K value for the wild type strain. R was 
measured as number of doubling events of optical density per hour, while 









Figure 3.3 Growth curves of mutant strains and wild type strain in four different 







Figure 3.5 continued Growth curves of mutant strains and wild type in four 
different conditions. Assays were repeated at 30C and at 37C, in YPD broth 
and in YNB broth. Each panel shows the wild type strain in red:  plotted 
against the mutant strain indicated in blue: . As growth is exponential, log 
values of the OD600 values were plotted on the y-axes. Time is plotted on the 










Figure 3.6 Growth metrics of mutants in all conditions relative to the wild type, 
YSD89   from their respective repeats presented as univariate scatter plots. 
“K” indicates carrying capacity of the culture, which was quantified by the 
maximum optical density reached. “R” denotes the overall rate of growth, while 
“T_gen” is the fastest doubling time to occur during the assay. Points are 
coloured according to genotype; ssa1∆/∆ ,  ssa2∆/∆ , sba1∆/∆ , aha1∆/∆ 





K or R values >1.00 indicate that the carrying capacity or the growth rate of 
that strain outperformed that of the wild type strain (Fig. 3.6). Values of <1.00 
for K or R indicate that the strain grew to a lower density, or more slowly than 
the wild type. The inverse is true for the T_gen values; >1.00 is a longer fastest 
doubling time than the wild type and <1.00 is shorter than wild type. The 
metrics were compared statistically by ANOVA and Tukey’s test.  
 
The carrying capacity (K) for all strains was very similar; almost all were within 
10% of the wild type K value and ANOVA analysis of this metric showed no 
significant deviation from the wild type in any condition (p>0.1). 
 
Growth rates and fastest doubling times are intrinsically linked values, Growth 
rates and fastest doubling times in both YPD and YNB at 30C were within 
10% of the wild type values for all strains. More variation was observed at 
37C, with only YSD661 and YSD813 differing from the wild type by less than 
10% in YPD. In YPD at 37C, the only strain to display a growth rate and 
generation time higher than the wild type was YSD662, which grew overall 
23.3% faster than the wild type strain, and had a shorter minimum doubling 
time by 18.9%. Nonetheless, these YSD662 did not significantly deviate from 
the wild type in any condition (p>0.05). The remaining strains; YSD816 
(sba1∆/∆), both ssa2∆/∆ mutants, both aha1∆/∆ mutants, and both sti1∆/∆ 
mutants had growth rates 10%-20% slower than the wild type, and minimum 
doubling times 11%-25% longer than the wild type. The ssa2∆/∆ mutant strain 




YPD at 37°C (p=0.024) in fastest generation time, while carrying capacity and 
growth rate were similar to the wild type. 
 
Conversely, in YNB at 37C, several strains outperformed the wild type strain 
in overall growth rates and minimum doubling times. Only the sti1∆/∆ mutant 
YSD874 grew more slowly than the wild type, with 18.7% slower growth rate 
and 23.1% longer minimum doubling time. Both sba1∆/∆ mutants and aha1∆/∆ 
mutants displayed faster growth rates and shorter minimum doubling times 
than the wild type strain. Their growth rates were faster by 12%-22%, and their 
minimum doubling times were shorter by 11%-18%. The remaining five strains 
all produced values within 10% of the wild type strain in this condition. 
Nevertheless, none of these differences were statistically significant (p>0.05). 
 
ANOVA analysis showed no statistical significance (p>0.05) in carrying 
capacity or in overall growth rate in any condition. For fastest generation time, 
there was a statistically significant difference in time in YPD at 37°C (p=0.018), 
while in the other three conditions the results were statistically similar. Pairwise 
comparison showed the outlier strain for fastest generation time in YPD at 
37°C was the ssa2∆/∆ strain YSD731, for which the fastest generation time 
was slower than the wild type (p=0.024). When taking into account that 
carrying capacity and growth rate did not differ significantly from the wild type, 
it was concluded that YSD731 did not have a substantial growth defect to 





Despite the lack of statistical significance, trends appear to emerge of small 
differences in growth behaviour between wild type and mutant strains. Both 
sti1∆/∆ mutants outperformed the wild type in most conditions, and were the 
only strains to grow more quickly than the wild type strain in YNB broth at 37°C 
(Fig. 3.6). All of the other strains, with the exception of the ssa1∆/∆ mutants 
grew at a faster rate than the wild type in YPD at 37°C, but then slower than 
wild type in YNB at the same temperature. As YNB is the synthetic defined 
media, this trend implies the mutant strains may thrive while nutrients are 
abundant, but struggle in nutrient-limiting conditions. This will be something to 
be mindful of in further investigation of these strains; potential defects in 
nutrient sequestration or intracellular storage. 
 
Based on the behaviour of these mutants, none of the co-chaperone genes 
investigated is required for growth under the conditions tested here, and 
deviations from the metrics of the wild type strain were minor. All of the Hsp90 











Transformation using lithium acetate is a reliable method but efficiency of the 
reaction is low, particularly for deletion of the second allele. Efficiency also 
differs between genes, depending on factors such as their genomic locale and 
heterochromatin formation. It is as yet not known whether this is because Tah1 
or an Hsp70 orthologue is essential for viability; it may be pertinent in future to 
try deletion of the genes by another method, such as the recently developed 
CRISPR [165]. Alternatively, the function of Tah1 and Ssa1/2 could be 
investigated through insertion of a repressible promoter in place of the native 
promoter to deplete protein levels in the cell. Established repressible 
promoters used in C. albicans are controlled by various means. These include 
manipulation of the carbon source, as in the CaMAL2 promoter [166], and 
addition of amino acids, as with the MET3 promoter [167]. The addition of 
antibiotics can also control expression, as with the tetracycline-repressible 
Tet-off promoter, which has been used to suppress other essential genes, 
such as HSP90 [168, 169]. Repressible promoters make it possible to deplete 
levels of essential proteins in cells and to observe the effects thereof. 
 
The growth curves show limited variation between the mutants and the wild 
type strains. More variation was observed at 37C than at 30C with growth in 
general being less predictable at the higher temperature. There was also more 
variation in YNB; the synthetically defined medium, than in YPD; the rich broth, 
suggesting discrepancies in the abilities of strains to grow robustly when 





The aim of the growth curve assays was to identify growth defects in mutants, 
as this was an undesirable trait when trying to identify strains essential for 
virulence but not for viability or growth. All of the strains were carried forward 
for further analysis of their virulence potential as none of the gene deletions 
conferred a growth defect. In fact, the largest differences in growth metrics 
were in cases when the mutant strain outperformed the wild type strain. 
 
Subtle trends were observed where growth metrics for most strains were 
clustered either above or below the wild type in the growth assays. This may 
be worthwhile revisiting in future by assaying strains for growth in conditions 
more closely imitative of the natural environment; with more nutrient limitation, 
over longer time periods, and with microbial competition, for example. 
However, for the purposes of this study, these results were considered 
adequately informative to dismiss a significant role of these co-chaperones in 
C. albicans avirulent growth. 
 
Homozygous gene deletion strains for Hsp90 co-chaperones were 
successfully generated for this study, and the initial growth assays show they 
are not essential for growth. Next, the roles of these co-chaperones in 







4. Characterisation of Hsp90 co-chaperone null 




Virulence factors are the pathogen’s armoury which enable it to invade, survive 
and thrive in the host. Pathogens with attenuated virulence may live as normal 
in the external environment, but fail to overcome a host’s defences. The C. 
albicans Hsp90 co-chaperones are largely uncharacterised and so their role 
in virulence is unknown. A set of in vitro virulence assays was carried out in 
order to quantify the importance of each co-chaperone in individual virulence 
traits. 
 
in vitro virulence assays allow for quantification of how different strains are 
able to manifest virulence factors, known to be important for infection. All of 
the strains generated and tested in this study are homozygous null for a single 
gene. This means that when a difference in phenotype is observed it can be 
deduced that the deleted gene is instrumental in the particular characteristic 
tested. However, it is important to note that when no difference in phenotype 
can be observed, it may not mean that the deleted gene plays no role in the 
phenotype; rather that it does not play a unique or essential role, and that the 





For the virulence assays, the strains are split into two groups; group one and 
group two. There were two mutants generated for each gene deletion, and 
each group contains one mutant of each pair. The wild type strain, YSD89, 
was used as a positive control in all assays and included in both groups. There 
was also a sterile control included in all replicates of all assays, and in some 




4.1 ssa2∆/∆ mutants are enhanced in oxidative stress resistance 
 
Resistance to oxidative stress is an important virulence trait for pathogens to 
survive in the host bloodstream. Oxidative burst is one of the primary defences 
of the innate immune system employed when phagocytes attack invading 
organisms with reactive oxygen species [13]. Phagocytes engulf invading 
pathogens and release reactive oxygen species into the phagosome to exert 
stress on the pathogen [170]. 
 
This assay was optimised using a hog1/ mutant, YSD883, as Hog1 is known 
to be important in oxidative stress resistance [171]. The hog1/ mutant was 
generated in the same background as the other mutants in this study; YSD89, 
for consistency in comparing the strains in this assay. A range of hydrogen 
peroxide concentrations were used in optimisation to find a dose which left the 




1 mM hydrogen peroxide was fatal for almost all hog1/ cells but the same 
concentration left more than 80% of wild type cells unaffected. This shows the 
clear distinction between a healthy response to oxidative stress and an 
attenuated response. Higher concentrations were shown to be detrimental to 
all strains, including the wild type, and so were too concentrated to test for 
defects in oxidative stress resistance. Due to the high rate of degradation of 
hydrogen peroxide, the concentration of the stock was checked regularly by 
spectrophotometer. 
 
Next, group one and group two mutants, each containing one mutant per gene, 
were compared for their relative colony forming unit (cfu) counts for treated 
and untreated cells (Fig. 4.2 and 4.3). The wild type strain, YSD89, shows 
approximately 10% die-off from exposure to hydrogen peroxide, and it was 
against this metric that the mutant strains were compared. The negative 
control strain, YSD883 (hog1∆/∆), clearly exhibits almost complete inability to 
survive exposure to hydrogen peroxide for one hour; a significant difference 
between this strain and the wild type strain (Table 4.1).  
 
Interestingly, the homozygous null mutants for SSA2; YSD702 and YSD731, 
both exhibited significantly increased resistance to oxidative stress relative to 
the wild type strain (p=0.009 and p=0.025, respectively). This is a consistent 
and convincing indication that the presence of Ssa2 in some way impedes the 







Figure 4.2 Oxidative stress assay results for group one mutants, plotted with 
positive and negative controls; wild type strain YSD89 and hog1∆/∆ strain 
YSD883, respectively. The data points denote viable colony forming units 
(CFU) from the diluted volume plated. The panel on the left shows counts for 
cells without oxidative stress treatment, and the panel on the right contains 
counts for cells exposed to 1 mM hydrogen peroxide. Data represent three 
technical replicates and three biological replicates. Crosses denote mean CFU 
counts, with standard error bars protruding: YSD89 wild type , YSD883 
hog1∆/∆ , YSD661 ssa1∆/∆ , YSD702 ssa2∆/∆ , YSD813 sba1∆/∆ , 






Figure 4.3 Oxidative stress assay results for group two mutants, plotted with 
positive and negative controls; wild type strain YSD89 and hog1∆/∆ strain 
YSD883, respectively. The data points denote viable colony forming units 
(CFU) from the diluted volume plated. The panel on the left shows counts for 
cells without oxidative stress treatment, and the panel on the right contains 
counts for cells exposed to 1 mM hydrogen peroxide. Data represent three 
technical replicates and three biological replicates. Crosses denote mean CFU 
counts, with standard error bars protruding: YSD89 wild type , YSD883 
hog1∆/∆ , YSD662 ssa1∆/∆ , YSD731 ssa2∆/∆ , YSD816 sba1∆/∆ , 









Table 4.1 p-values of survival of each strain relative to the wild type strain 
under oxidative stress calculated by a mixed linear model, with survival rate 
indicated in comparison to the wild type strain. Significance codes are; “***” 
p<0.001, “**” 0.001<p<0.01, “*” 0.01<p<0.05. 
 
STRAIN GENOTYPE SURVIVAL RATE LM P-VALUE 
YSD883 hog1∆/∆ Reduced <0.001*** 
YSD661 ssa1∆/∆ Reduced 0.175 
YSD662 ssa1∆/∆ Reduced 0.023* 
YSD702 ssa2∆/∆ Increased 0.009** 
YSD731 ssa2∆/∆ Increased 0.025* 
YSD813 sba1∆/∆ Reduced 0.339 
YSD816 sba1∆/∆ Reduced 0.177 
YSD868 aha1∆/∆ Reduced 0.119 
YSD871 aha1∆/∆ Reduced 0.445 
YSD874 sti1∆/∆ Reduced 0.047* 
YSD947 sti1∆/∆ Reduced 0.444 
 
 
The homozygous null mutants for SSA1; YSD661 and YSD662, show reduced 
resistance to oxidative stress relative to the wild type. However, this result was 
not significant for YSD661 (p=0.175), while YSD662 from mutant group two 
was significantly impaired (p=0.023). These results suggest that Ssa1 may be 
involved in the oxidative stress response. This is particularly surprising 
following the increase in survival of oxidative stress seen in the ssa2∆/∆ 




gene and protein sequences; 85.8% and 87.2%, respectively, that such 
opposing phenotypes in the mutants was not anticipated [116].  
 
The group one sti1∆/∆ mutant, YSD874, was impaired in its response to 
oxidative stress relative to the wild type with marginal significance (p=0.047), 
while in group two, YSD947 showed no reduction in oxidative stress resistance 
(p>0.1). This pair of mutants should be genotypically identical so a difference 
in results was not expected; second-site mutations may have occurred during 
the transformation reaction.  
 
Neither Sba1 nor Aha1 appear to play an important role in oxidative stress 
resistance, as the mutants’ survival under the conditions tested was 








4.2 Hsp90 co-chaperones do not appear to be required for heat shock 
tolerance 
 
Tolerance of heat shock is an important virulence trait in pathogens which 
induce fever in their hosts. Fever is a facet of the innate immune response 
which exerts high temperature as a form of stress on the invading pathogen 
[172, 173]. Tolerance of heat shock and thriving in heat shock conditions is 
indicative of the ability of the pathogen to adapt to the host environment. 
 
Under normal circumstances, high temperatures increase expression of 
HSP90; as implied by the name, “heat shock protein” [174]. The negative 
control strain in this assay was the tetOFF-HSP90/hsp90Δ strain, YSD106. 
Addition of 20 µg mL-1 doxycycline to the growth media reliably turns off HSP90 
gene expression, thus depleting Hsp90 protein levels [24, 156]. For this assay, 
doxycycline was added to the cultures when they were adjusted to OD600 0.2 
prior to being grown to mid-log growth. The effect of the reduced heat shock 
tolerance in this assay is stunted growth of the cultures. This means that while 
the wild type strain, YSD89, almost doubles in colony count over the two-hour 
period, which is consistent with normal yeast doubling time [175], the negative 












Figure 4.4 Heat shock assay results for group one mutants, plotted with 
positive and negative controls; wild type strain YSD89 and tetOFF-
HSP90/hsp90Δ strain YSD106, respectively. The data points denote viable 
colony forming units (CFU) from the plated culture dilution. The panel on the 
left shows counts for cells before heat shock treatment, and the panel on the 
right contains counts for cultures after two hours of incubation at 42C with 
orbital shaking at 200 rpm. Data represent five technical replicates and two 
biological replicates. Crosses denote mean CFU counts, with standard error 
bars protruding: YSD89 wild type , YSD106 tetOFF-HSP90/hsp90Δ , 
YSD661 ssa1∆/∆ , YSD702 ssa2∆/∆ , YSD813 sba1∆/∆ , YSD868 





Figure 4.5 Heat shock assay results for group two mutants, plotted with 
positive and negative controls; wild type strain YSD89 and tetOFF-
HSP90/hsp90Δ strain YSD106, respectively. The data points denote viable 
colony forming units (CFU) from the plated culture dilution. The panel on the 
left shows counts for cells before heat shock treatment, and the panel on the 
right contains counts for cultures after two hours of incubation at 42C with 
orbital shaking at 200 rpm. Data represent five technical replicates and two 
biological replicates. Crosses denote mean CFU counts, with standard error 
bars protruding: YSD89 wild type , YSD106 tetOFF-HSP90/hsp90Δ , 
YSD662 ssa1∆/∆ , YSD731 ssa2∆/∆ , YSD816 sba1∆/∆ , YSD871 





Table 4.2 p-values of growth of mutants at 42C relative to the wild type strain 
according to a mixed linear model. Significance codes are; “***” p<0.001, “**” 





While Candida albicans is adapted to living at 37C, a temperature of 42C 
constitutes heat shock. Mutants were exposed to heat shock for two hours and 
growth measured as cfu counts. Colony counts after heat shock were 
compared to those prior to heat shock and levels of growth were compared 
with that of the wild type for statistical analyses (Fig. 4.4 and 4.5).  
 
The ssa1∆/∆ mutant in group two, YSD661, was significantly impaired 
compared to the wild type strain (p=0.040), whereas its counterpart strain was 
STRAIN GENOTYPE RELATIVE GROWTH P-VALUE 
YSD106 HSP90/hsp90∆ Reduced 0.005** 
YSD661 ssa1∆/∆ Reduced 0.484 
YSD662 ssa1∆/∆ Reduced 0.040* 
YSD702 ssa2∆/∆ Reduced 0.056 
YSD731 ssa2∆/∆ Reduced 0.742 
YSD813 sba1∆/∆ Reduced <0.005** 
YSD816 sba1∆/∆ Reduced 0.895 
YSD868 aha1∆/∆ Reduced 0.780 
YSD871 aha1∆/∆ Reduced 0.759 
YSD874 sti1∆/∆ Reduced <0.002** 




not (Table 4.2). A similar disparity was seen with the sba1∆/∆ and sti1∆/∆ 
mutants, with the mutants in group one being impaired in heat shock tolerance, 
while the group two mutants were not significantly affected. The sba1∆/∆ and 
sti∆/∆ mutants from group one, YSD813 and YSD874 (p<0.005, p<0.002), 
were in fact even outperformed by the negative control strain, YSD106 
(p=0.005).  
 
The reasons for these stark differences in behaviour between what should be 
identical pairs of mutants is not clear, but may be due to second-site mutations 
having arisen during the transformation reaction. 
 
Both pairs of the ssa2∆/∆ mutants, YSD702 and YSD731, as well as both of 
the aha1∆/∆ mutants, YSD868 and YSD871, grew with comparable success 
to the wild type in heat shock conditions (Table 4.2). This suggests that neither 








4.3 sti1∆/∆ mutants are enhanced in morphogenesis on solid growth 
media 
 
C. albicans is known to grow in three distinct morphological forms; budding 
yeast, pseudohyphae, and hyphae, and the ability to transition between these 
is essential for causing disease [30]. Morphology of whole colonies provides 
information about morphological capabilities and changes in phenotype 
conferred by gene deletions.  
 
Colonies were grown on six different solid growth media and their 
morphologies compared to that of the wild type strain, YSD89 (Fig. 4.6). 
Colonies in the middle of the plate layout were omitted from the analysis as it 
was evident that their growth was impaired by proximity to other colonies. This 
meant that two technical replicates and three biological replicates were 
analysed for each strain, which yielded consistent results across replicates. 
Each colony was assigned a score according to growth and appearance, and 
compared to the wild type (Table 2.3). 
 
On YPD agar all strains grew with approximately equal robustness into the 
familiar butyrous white colony formation typical of C. albicans; 3 in the scoring 
scheme (Fig. 4.6, Table 4.3). This was effectively a control medium for growth 
at 37C and major differences in morphology were not expected. Particularly 
after having assessed the growth rates and capacities of these strains and 
found them to be similar, morphology on solid rich media was also expected 





Spider agar is a rich medium which induces hyphal formation and colony 
wrinkling in C. albicans at 37C [176]. Almost all of the strains formed wrinkled 
colonies with a filiform halo of hyphae, a score of 3 in the scheme. This means 
their phenotype on spider agar did not differ from the wild type strain, YSD89. 
The notable exception to this was YSD662, which formed glabrous colonies 
with little filiform halo, a score of 2 according to the scheme. This suggests the 
strain is defective in formation of wrinkles and of hyphae and, importantly, the 
same phenotype was not seen in YSD661; the strain with the same gene 
deletion.  
 
RPMI medium was originally formulated for culturing of mammalian cell lines, 
and imitates, without serum, nutrient conditions in the host bloodstream [177]. 
For Candida spp. RPMI is used to induce biofilm formation and to test for 
susceptibility of strains to antifungal drugs [178, 179]. All strains formed dry, 
rough, filiform colonies on RPMI. The only exception in this case was the 
sti1∆/∆ mutant YSD947, which formed only semi-filiform colonies. This is an 
interesting result as this strain exhibited no defects in hyphal formation on any 
other solid growth media. 
 
SD agar is a selective peptone medium used predominantly to grow fungi [180, 








Figure 4.6 Examples of colonies for each strain on each growth medium. “WT” 
indicates the wild type strain, while the mutant strains are labelled across the 
top by their genotype and YSD numbers. The column on the left indicates 
which growth medium the colonies are on. 
 
 
The Calcofluor White stain has an affinity to chitin and interferes with chitin 
synthesis and polymerisation, which is essential for proper cell wall formation 
[182, 183]. This affects cell morphology and Calcofluor White can have the 
effect of increasing yeast cell wall volume by up to 30% [184]. A range of 
colony morphologies was seen on this growth medium, with the wild type strain 
forming colony types 3 and 4 on the scheme; wrinkly, undulate colonies, and 
robust wrinkles on undulate colonies, respectively. Colony type 3 was 
predominant for the wild type strain, whereas the sti1∆/∆ mutants; YSD874 
and YSD947, formed exclusively colony type 4 with large, robustly wrinkled 
colonies. The ssa1∆/∆ mutant, YSD662, formed colonies which scored 2; 





Congo Red dye similarly affects formation of the fungal cell wall and therefore 
cell and colony morphology [185]. Most strains formed colony type 2 on this 
medium; haloed colonies with wrinkles all over. In the case of the sti1∆/∆ 
mutants; YSD874 and YSD947, the colonies grew larger than the other strains 
and formed more elevated wrinkles. These are the same strains which grew 
most robustly on SD agar with Calcofluor White. YSD662 again grew with less 
success than the other strains and formed colonies with only a wrinkled halo 
with a glabrous centre; colony type 1.  
 
 
Table 4.3 Morphology scores for colonies of each strain on each solid growth 
medium (Table 2.3). Scores are representative of colonies from all replicates 
as results were consistent. Colours denote equivalence, reduction, or 
enhancement relative to the wild type. 
 
WT ssa1∆/∆ ssa2∆/∆ sba1∆/∆ aha1∆/∆ sti1∆/∆ 
Medium 89 661 662 702 731 813 816 868 871 874 947 
YPD 3 3 3 3 3 3 3 3 3 3 3 
Spider 3 3 2 3 3 3 3 3 3 3 3 
RPMI 3 3 3 3 3 3 3 3 3 3 2 
CF White 3 3 2 3 3 3 3 3 3 4 4 
Congo red 2 3 1 2 2 2 2 2 2 3 3 







Lee’s medium is a synthetic defined growth medium which induces hyphal 
growth at 37C [186]. Colony morphology on this medium was consistent, with 
most strains forming colony type 2; dry, undulate colonies with elevated 
wrinkles. YSD662 was the only exception to this, forming colony type 1; dry, 
entire colonies with robust wrinkles. Some strains defective in biofilm formation 
are known to form colonies on Lee’s medium with few wrinkles, or even 
smooth, so the difference seen in YSD662 is quite minor. However, the 
different morphology was consistent; this was the only strain to form colony 
type 1 and it did so in all four technical replicates in all three biological 
replicates.  
 
Wrinkling of colonies is an indication of biofilm formation; cells in the colony 
excrete extracellular matrix, causing strain on the colony surface, where the 
cells act as an elastic skin [187, 188]. The importance of the wrinkles 
themselves are to increase surface area of the colony to help meet the oxygen 
demand as the colony expands, and have been found to provide channels for 
flow of nutrients through the extracellular matrix [189, 190]. 
 
The larger, more wrinkled colonies of the sti1∆/∆ strains on media containing 
Calcofluor White and Congo red dyes imply that Sti may regulate production 
of extracellular matrix, which is then overproduced in the null mutant. The 
colonies appear more robust than the other strains, but this may not translate 





The ssa1∆/∆ mutant, YSD662, is impaired in wrinkle-formation, but not hyphal 
growth, as filiform haloes were present on the colonies to the same extent as 
the wild type strain. Its divergence in morphology from YSD661 suggests that 
the cause is a second-site mutation, rather than the absence of Ssa1. The 
smooth colonies suggest that this strain produces less extracellular matrix and 




4.4 Aha1 and Sti1 are required for biofilm formation 
 
Biofilm formation is a potent virulence trait associated with nosocomial 
systemic infections and drug resistance [27]. Biofilms consist of cells 
surrounded by a network of extracellular polysaccharides, aiding in their 
coherence and adherence. This glutinous coating protects microbial 
communities from both the host immune system and drug treatments. The 
biofilm also acts as a reservoir of cells to seed the wider infection by gradual 
dispersal. Biofilm dispersal and drug resistance in C. albicans is directed by 
Hsp90 [63]. 
 
Measurements were taken of biofilm metabolic activity using colorimetric dye 
reduction and OD492 readings. As biofilms were washed before measurements 
were taken, this method means that strains defective in adherence would be 
classified as “weak”, as any biofilm formed would be washed off the surface. 




replicates containing 8 technical replicates each, with the wild type strain, YSD 
89, acting as the positive control for biofilm formation and adherence, and the 




Figure 4.7 Univariate dotplot showing the success of biofilm formation for all 
strains and all replicates, including the positive and negative controls; the wild 
type strain YSD89 and the bcr/ strain YSD174, respectively. Representative 







Results were analysed using ANOVA, which showed significance with 
p<0.001. This was followed by mixed linear analysis comparing each strain to 
the wild type strain and pairwise comparisons between mutant pairs. All of the 
strains were found to have significantly weaker biofilm formation compared to 
the wild type strain, with p<0.001 in almost every case (Table 4.4). The only 




Table 4.4 p-values of biofilm formation of mutant strains relative to the wild 
type strain, YSD89 according to chi squared 2x2 analysis. Significance codes 
are; “***” p<0.001, “**” 0.001<p<0.01, “*” 0.01<p<0.05. 
 
STRAIN 
GENOTYPE WT VS 
MUTANT MUTANT PAIRS 
YSD174 bcr1∆/∆ <0.001*** n/a 
YSD661 ssa1∆/∆ <0.001*** 
0.035* 
YSD662 ssa1∆/∆ <0.001*** 
YSD702 ssa2∆/∆ <0.001*** 
0.237 
YSD731 ssa2∆/∆ 0.015* 
YSD813 sba1∆/∆ <0.001*** 
0.028* 
YSD816 sba1∆/∆ 0.002** 
YSD868 aha1∆/∆ <0.001*** 
0.957 
YSD871 aha1∆/∆ <0.001*** 
YSD874 sti1∆/∆ <0.001*** 
0.580 






However, there were also statistically significant differences in biofilm success 
between pairs of mutants which should be identical; ssa1Δ/Δ and sba1Δ/Δ 
mutants all showed much lower biofilm success relative to the wild type strain, 
but differential success to one another to a marginally significant degree (Table 
4.4).  
 
The readings for most strains form a bimodal pattern; biofilms either adhered 
to the wells and gave a high OD492 reading, or were almost completely lost in 
the wash steps and gave a reading close to zero. The ssa1Δ/Δ and sti1Δ/Δ 
mutant pairs were the only strains to defy this trend, producing a much more 
even spread of readings up the scale. The reasons why these strains form 
biofilms in such an apparently inconsistent manner is as yet unclear.  
 
The ssa2Δ/Δ, aha1Δ/Δ, and sti1Δ/Δ mutant pairs showed no significant 
difference in success between the strains (Table 4.4). It can be concluded from 
this that Ssa2, Aha1 and Sti1 are instrumental in biofilm formation and 








4.5 Ssa2 increases antifungal drug susceptibility, while Sti1 plays a role 
in resistance 
 
Antifungal drug resistance is a growing threat to the already inadequate 
treatments for systemic fungal infections [191]. Azoles are the most 
commonly-prescribed antifungal drug class, and similar compounds are used 
in arable agriculture. For fungal pathogens, this high frequency of exposure to 
azoles, both in and out of medical settings, increases the selection pressure 
for the emergence of resistance.  
 
Hsp90 is instrumental in the evolution of drug resistance [35]. To assess 
whether Hsp90 is also relevant in co-chaperone-mediated drug resistance, 
growth of mutants in the presence of fungistatic fluconazole was measured 
and compared with the wild type strain. The same was then repeated with the 
addition of Hsp90 inhibitor to investigate how the inhibition of Hsp90 coupled 
with the absence of each co-chaperone would affect the tolerance of the 
strains to fluconazole. 
 
Growth in the presence of the drug was quantified by OD600 readings, which 
were normalised to the no-drug control. The strains exhibited high resistance 
to the fluconazole only condition, and so the minimum inhibitory concentration 
for inhibition of 40% of total growth (MIC40), rather than 50% (MIC50), as was 
used in the other two drug conditions. The MIC40 for the wild type strain was 8 





Both of the null strains for SSA2 showed increased resistance to fluconazole 
compared to the wild type strain, with MIC40 at a dose of 64 g mL-1. It is well 
established that Ssa2 mediates entry of histatin 5 into the cell, this result 
suggests this may also be the case for other antifungal compounds [114, 117]. 
 
Six strains, with three different genotypes, showed lower resistance to 
fluconazole than the wild type. This means that drug resistance is lower when 
SSA1, SBA1, and STI1 are not present in the genome, suggesting that Ssa1, 
Sba1 and Sti1 are positive regulators of the drug response. The MIC40 doses 
for the ssa1/ strains; YSD661 and YSD662, were 4 g mL-1 and 2 g mL-1, 
respectively. The optical density readings in the raw data (not shown) 
demonstrate that this is a small difference. For the sba1/ strains the MIC40 
doses were 2 g mL-1 and 4 g mL-1, respectively. The strains in this case 
show a considerable discrepancy in optical density readings, suggesting there 
may be an underlying difference in the genomes of the two strains, undetected 
by genotyping screens. The sti1/ strains had the same MIC40 dose of 4 g 
mL-1; one dilution lower than the wild type.  
 
The absence of AHA1 appears to have no effect on resistance to fluconazole, 
as MIC40 in this case remain stable at 8 g mL-1. The absence of a difference 
here suggests that Aha1 is not instrumental in either resistance or 












































































































































































































































































































































































































It was expected that the addition of geldanamycin and radicicol to the cultures 
would yield similar effects to one another as they are both Hsp90 inhibitors, 
although recent research suggests that they target it differently [192]. Hsp90 
plays an important role in drug resistance and so a low level of inhibition of its 
function can abrogate resistance to fluconazole, as well as other antifungal 
drugs [35, 89].  
 
Geldanamycin and radicicol were added to every well in the 96-well plates, to 
a final concentration of 5 M for both. Only fluconazole was added on a 
gradient ranging from 0 g mL-1 to 256 g mL-1. Growth in the wells without 
fluconazole reached the same optical density, regardless of the presence of 
geldanamycin or radicicol. This shows that 5 M of Hsp90 inhibitor alone does 
not affect overall growth success of the cells. The combination of Hsp90 
inhibitors with fluconazole, however, had a pronounced effect. 
 
With the addition of geldanamycin, the MIC50 dose of fluconazole was 1 g 
mL-1 for all strains except for the sti1/ strains; YSD868 and YSD871, which 
were inhibited by the lower concentration of 0.5 g mL-1. This emphasises the 
importance of Hsp90 as its inhibition renders the resistance levels of the 
mutant strains almost identical to the wild type and masks the effects of gene 
deletions seen in the fluconazole-only assay. 
 
When radicicol was added, the results were similar to geldanamycin; the MIC50 
dose was 1 g mL-1 for all strains, this time including the sti1/ strains. 




concentration as 1 g mL-1 in fact inhibited more than 65% of the growth. This 
is compared to only 30% inhibition at 0.5 g mL-1 fluconazole with 5 M 
radicicol, which is consistent with previous findings [193]. Sti1 plays an 
important role in drug resistance, meaning that combinatorial therapy using an 
existing antifungal with a Sti1 inhibitor may prove a useful tactic for treatment 




4.6 Ssa2 suppresses hyphal morphogenesis 
 
Formation of hyphae is known to be instrumental in causing infection, and 
mutants which are unable to undergo morphogenesis are avirulent. This is in 
part due to resistance to the host immune system, as yeast cells engulfed by 
macrophages will filament to escape [194]. 
 
To measure the ability of cells to switch from yeast to hyphal morphology, they 
were grown in 10% bovine serum for 90 minutes at 37ºC during log phase and 
measured in microscopy images. Odds’ morphology index was used to convert 
measurements from microscopy images of cells into a value for each cell, 
which could then be compared statistically [195]. A morphology index reading 
close to 5.0 is considered true hyphae. For each strain, 100 cells were 





The distribution of measurements for all strains is skewed, which is reflected 
in the average values as each median value is lower than the corresponding 
mean (Table 4.5). The mean morphology indices for each strain were 
compared by linear regression analysis and pairs of mutants were compared 
to one another by analysis of variance. 
 
The ssa2/ mutants both significantly outperformed the wild type strain in 
rapid hyphal formation. The boxplots clearly show that the spread of 
morphological indices for YSD702 and YSD731 extends further towards true 
hyphae than the wild type strain (Fig. 4.9, Table 4.5). Comparison between the 
data sets for the two ssa2/ mutants also shows that they behave almost 
identically to one another. Ssa2 is known to be a component of the hyphal cell 
wall so it interesting that its absence should lead to an increase in speed of 
hyphal formation, while also being impaired in biofilm formation [110].  
 
The mean morphology index for homozygous null mutant for SSA1, YSD661 
was almost identical to that of the wild type strain, YSD89. However, its 
counterpart mutant, YSD662 had a smaller average morphology index, with 
marginal significance (p=0.014). This means that YSD662 formed fewer 
hyphae than the wild type and the cell morphologies were on average closer 
to the round yeast shape. This result mirrors what was observed in the 
analyses of colony morphology on solid growth media (Fig. 4.6). When 
YSD661 and YSD662 were compared to one another by ANOVA they were 





The sba1/ strains, YSD813 and YSD816, both showed increased hyphal 
formation relative to the wild type. For YSD813 this was a significant increase 
(p=0.002), whereas for YSD816 the difference was insignificant. However, 
ANOVA comparison between the two data sets for YSD813 and YSD816 




Figure 4.9 Boxplots of morphology indices. Data are based on 100 cells for 
each strain. Horizontal bars show mean and interquartile range for each strain, 
while vertical extending bars show the extreme ends of the values. Dots 






Table 4.5 Summary of hyphal morphogenesis, including mean and median 
morphology index values for each strain, and statistical p-values. “+/-“ denotes 
whether the morphology index for each strain is larger (+) or smaller (-) than 
the wild type strain. “LM p-value” denotes the p-values generated by the mixed 
linear model used, “A p-value” are the p-values from ANOVA comparison 
between the mutant pairs. Significance codes are; “***” p<0.001, “**” 
0.001<p<0.01, “*” 0.01<p<0.05. 





YSD89 Wild type 2.107 1.797 n/a n/a n/a 
YSD661 ssa1∆/∆ 2.158 1.896 + 0.669 
0.004** 
YSD662 ssa1∆/∆ 1.806 1.502 - 0.014* 
YSD702 ssa2∆/∆ 2.525 2.424 + 0.003** 
0.919 
YSD731 ssa2∆/∆ 2.546 2.245 + 0.002** 
YSD813 sba1∆/∆ 2.537 2.100 + 0.002** 
0.070 
YSD816 sba1∆/∆ 2.245 1.894 + 0.214 
YSD868 aha1∆/∆ 2.181 1.897 + 0.671 
0.119 
YSD871 aha1∆/∆ 1.946 1.717 - 0.181 
YSD874 sti1∆/∆ 2.642 2.233 + <0.001*** 
0.011* 




Neither of the homozygous null mutants for AHA1 differed significantly from 
the wild type in speed of hyphal formation. YSD868 had a very slightly higher 
morphology index than the wild type, while YSD871 was slightly lower (table 
4.4) so the absence of Aha1 was deemed to have no impact on hyphal 





Homozygous null mutants for STI1 significantly differed from one another in 
speed of hyphal formation (p=0.011). The disparity is evident in the boxplots 
(fig. 4.8) with the spread of values for YSD874 extending further towards the 
higher end of the scale. YSD874 significantly outperformed the wild type strain 
in speed of hyphal formation (p<0.001), while the difference for YSD947 was 
insignificant (p=0.534).  
 
Differences in speed of hyphal formation are, with the exception of ssa1/ 
strain YSD662, all due to mutants outperforming the wild type strain. These 
results defy expectations as morphological switching between yeast and 
hyphal growth is considered an indispensable virulence trait [29, 30], and 
deletion of Hsp90 co-chaperone genes was anticipated to confer defects in 








4.7 ssa1∆/∆ mutant pair disparities suggest second-site mutations 
 
The phenotypes observed in the mutant pairs, which should be phenotypically 
identical, are far more variable than expected (Table 4.6). It is possible that 
second-site mutations occurred in the transformation process which colony 
PCR genotyping could not detect, as it is only designed to confirm deletion of 
the intended allele. It is also possible that the variations are due to noisy 
phenotype data, and so it is important to consider the overall trends observed. 
In all assays, the ssa2∆/∆ and aha1∆/∆ mutant pairs behaved identically to 
one another, suggesting that these strains are indeed genotypically identical.   
 
The sba1∆/∆ mutants exhibited differential behaviour in heat shock and drug 
resistance, but were both identical to wild type in oxidative stress and colony 
morphology. However, despite differences in the drug resistance assay, the 
sba1∆/∆ mutants exhibited a similar trend of reduced drug resistance relative 
to the wild type strain.  
 
The sti1∆/∆ mutants showed disparity in oxidative stress, heat shock, and 
hyphal formation, while being identical in the other three virulence assays. As 
well as statistical disparities, the sti1∆/∆ mutants exhibit different trends, with 
the group one mutant showing defects, while the group two mutant more often 
shows no phenotypic difference relative to the wild type. 
 
The ssa1∆/∆ mutants were the most dissimilar pair, showing differential 




just statistically in the assaya but also exhibit opposing trends; for example, in 
the colony morphology assay (Table 4.6). The ssa1∆/∆ mutants showed the 
same trends as one another only in the biofilm formation and drug resistance 
assays, but still behaved differentially in both of those. This is a strong 
suggestion that there are more differences in the genome than the single 
homozygous gene deletion attempted and there may be multiple second-site 
mutations, with a range of phenotypic effects. Genome sequencing is 
advisable here to identify the mutations that have arisen and identify the cause 
of disparities abserved.  
 
The heat shock assay delivered the least consistent results of the in vitro 
virulence assays carried out here. As well as investigating differences of 
behaviour in the mutants it may be worthwhile to invest in further refinement 
and optimisation of some of the protocols employed. 
 
 
Table 4.6 Summary of virulence assays outlining where mutant strains differed 
from the wild type and whether the virulence trait was reduced, enhanced, or 
unchanged. The “disparity” column states whether the mutant pairs behaved 
differently to one another. 
 
ASSAY GENOTYPE GROUP 1  GROUP 2  DISPARITY 
Oxidative 
stress 
ssa1∆/∆ None Reduced Yes 
ssa2∆/∆ Enhanced Enhanced No 
sba1∆/∆ None None No 
aha1∆/∆ None None No 




ASSAY GENOTYPE GROUP 1  GROUP 2  DISPARITY 
Heat shock 
ssa1∆/∆ None Reduced Yes 
ssa2∆/∆ None None No 
sba1∆/∆ Reduced None Yes 
aha1∆/∆ None None No 
sti1∆/∆ Reduced None Yes 
Colony 
morphology 
ssa1∆/∆ Enhanced Reduced Yes 
ssa2∆/∆ None None No 
sba1∆/∆ None None No 
aha1∆/∆ None None No 
sti1∆/∆ Enhanced Enhanced No 
Biofilm 
formation 
ssa1∆/∆ Reduced Reduced Yes 
ssa2∆/∆ Reduced Reduced No 
sba1∆/∆ Reduced Reduced Yes 
aha1∆/∆ Reduced Reduced No 
sti1∆/∆ Reduced Reduced No 
Drug 
resistance 
ssa1∆/∆ Reduced Reduced Yes 
ssa2∆/∆ Enhanced Enhanced No 
sba1∆/∆ Reduced Reduced Yes 
aha1∆/∆ None None No 
sti1∆/∆ Reduced Reduced No 
Hyphal 
formation 
ssa1∆/∆ None Reduced Yes 
ssa2∆/∆ Enhanced Enhanced No 
sba1∆/∆ Enhanced None No 
aha1∆/∆ None None No 







Homozygous null mutants for SSA2 appear in most virulence traits to be 
unimpaired, or even to have an advantage over the wild type strain, YSD89. 
Thus, Ssa2 appears to be a negative regulator of virulence traits, which are 
therefore enhanced in its absence.  
 
SSA2 expression is known to be repressed by caspofungin, while human ß-
defensins depend on the presence of Ssa2 on the cell surface for their 
candidacidal activity [196, 197]. Coupled with the effect of increased virulence 
found here, this suggests that employing Ssa2 as a drug target would be ill-
advised. 
 
It was already known that Ssa2 binds antifungal compounds on the surface of 
the cell, and that its absence therefore confers resistance to some antifungal 
compounds [114, 117]. It was, however, not previously known that deletion of 
SSA2 could confer phenotypic advantages in oxidative stress and hyphal 
morphogenesis and the reasons for this are thus far unclear. Ssa2 may have 
a general role in binding extracellular compounds, and therefore increases 
susceptibility to oxidative stress as well as to antifungal drugs. It is possible 
that the accelerated growth of hyphae in the mutants may also compromise 
integrity of the hyphal cell wall structure and thus compromise fitness, but this 





As an Hsp70 orthologue, Ssa2 has been implicated in heat shock tolerance 
but the homozygous null mutants showed no defects in this study. This result 
may be explained by the similarity of Ssa1 and Ssa2; with 87.2% protein 
sequence identity [116], it is possible that Ssa1 is compensating for the 
absence of Ssa2, and vice versa. Quantification of Ssa1 and Ssa2 protein 
expression in these strains compared to the wild type may show whether they 
are each upregulated in response to the other’s absence.  
 
It was attempted here to ascertain whether the two Hsp70 orthologues, Ssa1 
and Ssa2, compensate for the absence of one another by generating 
homozygous null mutants for both genes. This was a fruitless venture with the 
NAT recyclable marker, which may be due either to one Hsp70 orthologue 
being required for viability, or to the inefficiency of the reaction. This gene 
deletion may be attempted in future using the CRISPR method [165], or 
repressible promoters could be cloned in place of the native promoters to 
deplete protein levels and investigate essentiality and Ssa1 and Ssa2 in 
combination [198]. 
 
The group two ssa1∆/∆ mutant, YSD662, did exhibit lower tolerance to heat 
shock, but as the mutants are clearly different to one another, this may not be 
due to the deletion of SSA1. The pair showed similar discrepancies throughout 
all virulence assays, with YSD662 being the weaker strain in every case. 
Genome sequencing would help to solve this mystery and identify the 
additional mutations which are conferring these phenotypes. Although 




be required for hyphal formation in heat shock conditions, which highlights the 
limitations of testing virulence traits individually [199]. 
 
The role of Sba1 in these virulence traits is not entirely clear due to the 
disparity of behaviour between the two strains. A role in oxidative stress 
resistance can be confidently ruled out as neither strain deviated significantly 
from the wild type strain in that assay. It can likewise be stated that Sba1 is 
important for biofilm formation and for fluconazole resistance as both strains 
were defective in these traits, though to differing degrees. It is as yet uncertain 
whether these differences are due to experimental variation, or to underlying 
mutations in the genome having arisen in transformation. 
 
However, the group one sba1∆/∆ mutant (YSD813) exhibited a defective heat 
shock response and faster speed of hyphal formation, while YSD816 
performed the same as the wild type strain in these conditions. It is therefore 
not known to what degree Sba1 is involved in the heat shock response or in 
growth of hyphae. However, absence of the wild type allele in both strains was 
confirmed in duplicate by colony PCR, suggesting that the defects observed 
in YSD813 are likely to be due to second-site mutations. 
 
The homozygous null mutants for AHA1 were found to have defects only in 
biofilm formation, but in no other virulence assay here. Although AHA1 
expression is upregulated in response to oxidative stress and in biofilms [15, 
122], these results suggest that it is not actually required for most virulence 




orthologue in S. cerevisiae has been shown to increase competitive fitness 
[200]. 
 
Sti1 appears to be required for biofilm formation; although morphology of the 
null mutants appeared to be enhanced relative to the wild type on solid media 
they then performed poorly in the biofilm assay. As the biofilm assay includes 
wash steps, it may be that Sti1 specifically regulates biofilm adherence, which 
is then compromised in its absence. This is consistent with findings from the 
STI1 orthologue in S. cerevisiae [201]. 
 
For most of the strains tested, the data produced for the biofilm formation 
assay was bimodal in nature. Strains either successfully formed biofilms with 
high metabolic activity readings, or biofilms were completely washed off the 
surface before readings were taken. The negative control strain, bcr1∆/∆, was 
an extreme example, forming exclusively biofilms which were completely 
washed off. Otherwise, the ssa1∆/∆ and sti1∆/∆ mutants were the only strains 
not to conform to this pattern and produce a spread of OD492 readings along 
the scale.  
 
Very low biofilm readings were considered to be due to poor adherence, as 
biofilms did form, but were washed off the surface easily. Anecdotally, biofilms 
which produced very low readings were washed off the surface whole, while 
intermediate readings were produced when the biofilm came apart slightly 
wash steps. It appears that as well as biofilm formation and adherence, there 




the cells to adhere to one another as well as to the surface of the plate. This 
effect may be of relevance in a clinical setting; as an opportunistic pathogen, 
if C. albicans is already present in the host, its ability to form biofilms which 
adhere strongly to an inorganic surface may be less relevant than the strength 
with which the cells adhere to one another. 
 
The trend of Hsp90 co-chaperone null mutants outperforming the wild type 
strain in speed of hyphal formation was not anticipated. The reason may lie in 
a mechanism of suppression of hyphal formation, which is compromised when 
these genes are deleted. Hyphal formation is known to be important for biofilm 
formation, but these mutant strains with faster hyphal formation were all 
defective in biofilm formation. It appeared that defects in adherence were more 
relevant to the lack of success for mutant strains in the biofilm assays; all 
strains formed biofilms, which were then lost in the wash steps. Additionally, 
strains which form hyphae more quickly may not necessarily form hyphae of 
equivalent structural integrity than the wild type strain.  
 
It remains, even now, common practice to generate a single null mutant to 
investigate the role of a gene in C. albicans virulence phenotypes [202-204]. 
The results presented here demonstrate the importance of corroborating 
phenotype data with multiple mutants, as results between mutant pairs can 
show significant disparities. Desite the rigorous verification of gene deletion 
completed in the previous chapter, in vitro virulence studies suggest the 
possibility of underlying mutations, especially in the ssa1∆/∆ mutant strains, 





Alternatively, the disparities observed, especially the smaller disparities as 
seen in the sba1∆/∆ and aha1∆/∆ mutant strains may be due to noisy 
phenotype data produced as an artefact of the protocols used. Protocols were 
optimised using the extremes of positive and negative controls, with the wild 
type strain and null mutants such as the hog1∆/∆ and bcr1∆/∆ strains. 
However, they may not be adequately refined to prevent random variation from 
confounding the results. The phenotypes observed here should be 
investigated more thoroughly, using alternative methods and more null mutant 
strains. 
 
It should also be stated that when a single null mutant is investigated, a 
complemented strain is typically also generated, to establish that wild type 
phenotype is restored to the organism when the wild type gene is restored to 
the genome. This is, however, not always the case, and confirmation of the 
effects of gene deletion should be carefully considered. 
 
It is impossible to state the importance of particular virulence traits when tested 
individually, in vivo testing gives a more complete picture of the pathogenic 









5. Characterisation of Hsp90 co-chaperone null 
mutants in in vivo virulence assays with 




Virulence assays in vivo are a holistic approach for comparing the virulence of 
different strains. Significant defects in individual virulence traits may not 
always preclude strains from causing morbidity in a host and so the use of a 
host model compliments the use of in vitro virulence assays. Testing of 
individual virulence traits can never be exhaustive and in vivo virulence assays 
help to give a full and clear picture of the differences in virulence between 
strains. Manduca sexta fifth instar larvae were used in this study as an 
invertebrate model in keeping with the NC3R guidelines to reduce usage of 
vertebrate hosts [149]. The University of Bath maintains an inbred population 
that is maintained by a technician following standard operational protocols, 
ensuring continuity. The colony is regularly used for research, including 
bacterial and parasitic infection studies [205-207].  
 
It is difficult to ascertain from individual virulence assays how important each 
trait is in the context of an animal infection. Animal models are a useful tool for 






5.1 C. albicans infection causes morbidity and mortality in Manduca 
sexta fifth instar larvae 
 
This use of Manduca sexta as a model host organism for fungal infections is 
pioneering [160]. They are however well-established for use in research of 
flight mechanics [208], toxicology  [209-211], and as a model of bacterial 
infection, including E. faecalis and S. pneumoniae [146-148]. The crop-pest 
larvae lend themselves to a study of this type for a number of reasons. Firstly, 
the caterpillars are cheap to use and carry few ethical implications in 
comparison to vertebrate infection models, such as mice. Secondly, unlike 
Galleria melonella, which are commonly used as fungal infection models, M. 
sexta larvae are large enough to be injected with a precisely defined dose of 
fungal cells, and the horn can be clipped to take samples of haemolymph for 
analysis of the progression of infection during the experiment if desired. 
Finally, Manduca sexta hail from tropical climes [212] and thus the experiment 
can be run at the physiologically relevant temperature of 37C, which is often 
not the case when using invertebrate infection models. 
 
The University of Bath hosts a colony of Manduca sexta, also known as the 
tobacco horn worm. The colony has been inbred since 1978 and so individuals 
are genetically similar, making them useful for experimental consistency. 
Research on animals is carried out according to the principles of the National 
Centre for Replacement, Refinement & Reduction of Animals in Research 





The experiment starts with caterpillars shedding from fourth instar to fifth 
instar, and finishes when they are beginning to pupate. During this stage in 
development the animals will normally increase in body weight up to five-fold; 
almost doubling each day. A significant infection disrupts their development, 
so changes in body weight can be used as a measure of morbidity. The 
animals are also screened each day for death. 
 
What is unknown about the University of Bath Manduca sexta colony is how 
much the animals differ genetically from the published genome [150] having 
been inbred for almost four decades. In future, the Diezmann lab intends to 
re-sequence the genome for the University of Bath colony, using the 
established phenol chloroform method for genomic DNA extraction from 
insects [213]. The M. sexta genome is known to exhibit significant variation 
between male and female, with female animals having the repetitive W 
chromosome, not present in male animals [214]. Sexual dimorphism begins in 
early larval development, with female animals ultimately growing larger than 
male animals [215]. Dimorphism is known to apply also to the immune system, 
though evidence for this suggests this divergence begins at a more mature 
stage than the animals used in this study. There is no statistical indication of 
sex differences in susceptibility to infection between male and female animals 
used in in vivo infection models [216]. Animals in this study were not screened 
for sex so it cannot now be determined whether this caused any discrepancies 
in the data. However, animals were selected and assigned to groups at 
random so there should be an approximately equal balance of male and 





For these assays, the strains are split into two groups, as before; group one 
and group two, each containing one mutant of each pair. The wild type strain, 
YSD89, was used as a positive control in all assays and included in both 




5.1.1 Deletion of SSA1 reduces C. albicans morbidity in M. sexta 
 
Systemic infections, including C. albicans, are well-known to cause loss of 
body weight as a major symptom [217]. Changes in body weight were used as 
a measure of morbidity in this study and animal weights were measured at 24-
hour intervals and compared to the saline control. Animals were weighed daily 
until either the end of the assay, or until they succumbed to infection. 
 
The starting weight of animals was measured on day 0 and analysed by 
ANOVA to ensure that animals in different treatment groups were 
approximately the same weight. No significant differences were found 
between different treatment groups within any biological replicate, with p-
values ranging from p=0.776 to p=0.999. However, variation in initial starting 
weight is evident from the plots (Fig. 5.1 and 5.2) as the batches of caterpillars 
can develop at differing speeds. This was accounted for in the analysis as 







Figure 5.1 The weights of Manduca sexta larvae which survived at least one 
day following infection with group one mutants. The wild type strain does not 
appear as none of the animals infected with YSD89 survived 24 hours and so 
no weight changes were observed. The data points denote caterpillar weights 
in grams plotted against time in days. Data represent three biological 
replicates. Crosses denote mean weights, with standard error bars protruding: 
YSD661 ssa1∆/∆ , YSD702 ssa2∆/∆ , YSD813 sba1∆/∆  , YSD868 






Figure 5.2 The weights of Manduca sexta larvae which survived at least one 
day following infection with group two mutants. The wild type strain does not 
appear as none of the animals infected with YSD89 survived 24 hours and so 
no weight changes were observed. The data points denote caterpillar weights 
in grams plotted against time in days. Data represent three biological 
replicates. Crosses denote mean weights, with standard error bars protruding: 
YSD662 ssa1∆/∆ , YSD731 ssa2∆/∆ , YSD816 sba1∆/∆ , YSD871 







Morbidity was quantified in surviving animals by changes in body weight. 
Negative control animals, injected with saline only, gained weight extremely 
quickly over the course of the experiment; typically starting on day zero under 
2.5 g and finishing on day three between 7.5 g and 10 g. This is normal 
development and demonstrates that the injection of fluid in itself does not exert 
significant stress on the animals. 
 
Animals injected with phosphate buffered saline (PBS) were used as the 
control group for statistical analyses of body weight changes in the study. The 
weights of groups were analysed using ANOVA, which showed significance in 
weight comparisons between treatments on day one (p<0.0001). This was 
followed by Dunnet’s test for multiple comparisons between the weights of 
animals infected with each strain and the PBS control animals. These again 
show statistical significance as the control animals developed normally but the 
infected animals lost weight; the p-values for the Dunnet’s test on day one 
were p<0.0001 for all strains except the ssa2∆/∆ mutant strains, which were 
p=0.0002. This means that infection with all strains caused severe morbidity 
and impaired proper development and growth. Thus, deletion of the co-
chaperone genes, though they may be involved in virulence, did not abolish 
virulence.  
 
On days two and three, the waning numbers of surviving animals mean that 
the statistical analyses lose power. On day two, the ANOVA test still showed 
a significant difference in body weights between the treatment groups 




to the PBS control animals was only significant for the animals infected with 
the ssa1∆/∆ mutant strains (p=0.0188). This is because the severely affected 
animals had succumbed to infection, while the small number of unaffected 
animals continued to gain weight and increase the mean body weight of the 
group.  
 
On day three, with only very few animals remaining, the analyses ceased to 
show any statistical significance in differences of body weights between the 
treatment groups in any test. In the future, a larger scale of study may help to 
combat this challenge. Or, alternatively, refining the initial infective dose to an 
amount which causes morbidity but a lower rate of mortality may serve to make 
body weight data more informative statistically.   
 
The response of infected animals became bimodal; they would either appear 
unaffected by the pathogen and gain weight as normal, or lose weight before 
dying. Based on daily observations and inspections, animals appear to lose 
weight due to a combination of loss of appetite and dehydration. The 
usefulness of the mean values in recording weights is dubious; smaller 
animals die early on in the study and thus the remaining survivors carry undue 
significance in increasing the average weight. 
 
The bimodal effect in weight-gain is most evident in cases when the infection 
was most abiding, for example in the two animals which survived until day 




unaffected and grew to over 10 g, while the other lost a small amount of weight 




Figure 5.3 Experimental subjects one day post infection. (A) Live caterpillar 
from the control group, injected with saline only, and (B) dead caterpillar 
following injection with the wild type strain, YSD89. 
 
 
Symptoms of morbidity could also be detected visually, with afflicted animals 
gradually becoming discoloured with spots of melanisation (Fig. 5.3). This was 
a useful indication at each time point of whether an animal was likely to survive 
until the next day. They are typically lethargic in isolation even when healthy 
and so the colour of the animals was indicative of morbidity in the absence of 
behavioural traits. Anecdotally, it also appeared evident that animals suffering 
from symptoms were more irritable and sensitive to touch. If this is indeed the 
case then it may be related to the loss of appetite observed in afflicted animals 





The injection method means that strains in this assay can still cause disease 
with significant impairment of invasion. To test the capacity of mutant strains 
to colonise and invade healthy animals it may be possible in future to develop 




5.1.2 Deletion of Hsp90 co-chaperones slows mortality in an invertebrate 
model of infection 
 
Manduca sexta fifth instar larvae were injected in the rear right proleg with 106 
cells in 100 L phosphate buffered saline (PBS) and kept at 37C for the 
duration of the experiment. The wild type strain, YSD89 was used as the 
positive control, and killed all animals within 24 hours of inoculation.  
 
PBS was used as the negative control; animals were injected with the same 
volume of saline without cells to verify that they were not stressed by the 
injection procedure itself. All of the negative control animals survived to the 
end of the assay. In both groups of mutants, a log rank test showed a 
significant difference between the treatments (p<0.0001). The PBS control had 
a disproportionate effect on the analysis as all individuals survived, and so was 
excluded from the remaining analyses. When excluded, there was still 
significant difference found between the different treatments; p=0.036 in group 








Figure 5.4 Kaplan-Meier plot showing survival of fifth instar Manduca sexta 
larvae infected with group one mutants. The wild type strain, YSD89, was used 
as a positive control; saline as negative control. Data represent 10 technical 
replicates and 3 biological replicates. For visibility of data for all strains, y 








Figure 5.5 Kaplan-Meier plot showing survival of fifth instar Manduca sexta 
larvae infected with group two mutants. The wild type strain, YSD89, was used 
as a positive control; saline as negative control. Data represent 10 technical 
replicates and 3 biological replicates. For visibility of data for all strains, y 







All of the mutant strains exhibited statistically significant differences in the 
Kaplan-Meier curves relative to the wild type strain; none of them killed all of 
the animals within one day (Fig. 5.4 and 5.5). The most significant differences, 
consistent in both groups of mutants, were in the ssa1∆/∆ and aha1∆/∆ 
mutants, which left the largest proportions of surviving animals one day post-
infection. 
 
The curves for the ssa1∆/∆ mutants; YSD661 and YSD662, differed 
significantly from the wild type YSD89 curves (Table 5.1). This is in keeping 
with findings from a murine model of infection, where ssa1∆/∆ mutants showed 
attenuated virulence [110]. The aha1∆/∆ mutant curves; YSD868 and 
YSD871, also differed significantly from the wild type curves (Table 5.1). The 
aha1∆/∆ mutants were the only ones for which the group two mutant, YSD871, 
exhibited slightly less significance in the difference of the killing curve 
compared with the wild type. In all other strains, the mutant in group two had 
a lower p-value in the killing curve log-rank test. While the pairs of mutants 
should be genetically identical, this trend may be due to differences in the 
groups of animals. The average starting weight for the animals infected with 
group two mutants was clearly higher than for those infected with group one 
mutants (Fig. 5.2). This strongly implies that the yeasts were less able to kill 
the larger animals when the dose was the same. However, as the death rate 






The ssa2∆/∆ and sba1∆/∆ mutants also showed significance in Kaplan-Meier 
analysis (Table 5.1), meaning that they are significantly less able to kill the 
invertebrate host than the wild type strain. 
 
 
Table 5.1 p-values for survival of animals infected with mutant strains relative 
to the wild type, calculated by Mantel-Cox log-rank tests. Significance codes 
are; “***” p<0.001, “**” 0.001<p<0.01, “*” 0.01<p<0.05. 
 
STRAIN GENOTYPE P-VALUE 
YSD661 ssa1∆/∆ 0.003** 
YSD662 ssa1∆/∆ <0.001*** 
YSD702 ssa2∆/∆ 0.011* 
YSD731 ssa2∆/∆ 0.001*** 
YSD813 sba1∆/∆ 0.035* 
YSD816 sba1∆/∆ 0.002** 
YSD868 aha1∆/∆ 0.001** 
YSD871 aha1∆/∆ 0.002** 
YSD874 sti1∆/∆ 0.037* 




The sti1∆/∆ mutants showed the least significance in comparison with the wild 
type with p=0.037 for YSD874 and p=0.031 for YSD947. This suggests that 
STI1 is the least important of the genes tested in these types of infection (Fig. 




closer in virulence capability to the wild type strain. However, that this result is 
still significant demonstrates that all of the co-chaperones tested here play a 
role of consequence in the killing of an invertebrate host. 
 
In cases where the ability to kill is impaired, it manifests in this assay as a 
delay in killing, rather than an inability to kill at all (Fig. 5.4 and 5.5). There was 
no case in which more than 12% of animals survived until the end of the assay. 
Thus, the differences in the curves were significant, but ultimately most of the 
animals died of infection from every strain. It remains to be seen whether this 
effect has a useful application. However, evidence shows that a delay in 
treatment of systemic C. albicans infections increases the rate of mortality 
enormously [218, 219]. 
 
The Kaplan-Meier analysis, which takes into account time as a variable over 
the course of the infection, was followed by Cox’s hazard ratio analysis, which 
does not. This means that while the shapes of the Kaplan-Meier curves may 
be significantly different, removing the time variable means that only the 










Figure 5.6 Hazard ratios for all strains compared with the wild type strain 
YSD89. Group one mutants are plotted on the left-hand side, group two 
mutants are plotted on the right. The points indicate the hazard ratios, while 
the error bars show the 95% confidence intervals. The dotted line marks a 




The proportional hazard ratios for all of the mutant strains are lower than that 
of the wild type (Fig. 5.6), meaning that the risk of animals dying over the whole 
course of the infection experiment is lower with the mutant strains than with 
the wild type strain. However, all of the error bars for the 95% confidence 
interval extend above 1.0, meaning that overall there is no statistically 











All of the co-chaperone mutant strains demonstrate a slower rate of mortality 
than the wild type strain, which may be clinically useful where it is essential for 
treatments to be administered quickly. However, while they were hypothesised 
to have reduced virulence capability, the mutants ultimately caused severe 
morbidity and mortality in the animals.  
 
Immunity of the host is an important factor which varies significantly between 
different species. Data has shown that even with the virulence-attenuated C. 
albicans hog1/ mutant, while the M. sexta larvae are impervious to the 
disease, they do not rid the infection from the body and yeast can still be found 
in the haemolymph and the haemocoel [160]. This is an important factor to 
consider, however, as C. albicans typically causes systemic infections in 
immunocompromised individuals, an inability to clear the infection, even when 
virulence is undermined, may be a common feature [9, 217]. Undermining the 
ability of the organism to cause morbidity may nevertheless be useful in this 
case as a means of indirectly increasing the tolerance of the patient to the 
presence of fungal infection in the bloodstream [220]. This may allow for 
adequate extension of life so that infection can be cleared by application of 
alternative antifungal treatments in combination with anti-virulence agents. 
 
It would be useful in future to investigate further the persistence of these 




points. This would be particularly interesting in the cases of those caterpillars 
which exhibit no symptoms of infection.  
 
Ssa1 is known to mediate host cell invasion and null mutants show reduced 
virulence in mammalian models of infection [118]. The delay in killing by 
ssa1∆/∆ observed in M. sexta may be a differential manifestation of the same 
effect, with altered presentation due to the differences in the host immune 
system and its failure to clear infection. 
 
In future, it would be prudent to refine the optimisation of this assay with a 
dose-response curve, identifying a specific dose of the wild type strain which 
results in 50% mortality over the whole course of the assay, This would be 
useful in allowing for detection of strains which are enhanced in virulence 
potential, as well as those which are reduced.  
 
This is infection of an invertebrate animal model over a short period of time so 
conclusions cannot be drawn about how this effect would translate into other 
species. Factors to be taken into account include invasion, immunity, and time. 
Any incapacity of the mutants to invade a healthy animal will have been largely 
masked by the use of the injection method. This was a choice made in order 






6. Measuring the effects of histone deacetylase 





6.1 Histone deacetylases regulate telomeric gene expression 
 
Histone deacetylases are instrumental in chromatin formation in the telomeric 
regions of the genome, which suppress gene expression by making the genes 
inaccessible to molecular transcription machinery [130]. The telomere position 
effect (TPE) is a silencing mechanism which regulates expression of genes in 
telomeric regions and is understudied in fungi [221]. In human cells telomere 
length has been found to affect the mechanisms of TPE, and therefore how 
telomeric genes are differentially expressed as cells age [222]. Due to the 
trend of virulence genes being located in sub-telomeric regions, it is 
hypothesised that TPE regulation is relevant in C. albicans virulence [3-5]. 
 
Sub-telomeric derepression is known to be instrumental in host cell invasion 
in Candida glabrata [223], but its importance in C. albicans virulence is not yet 
known. Heterochromatin-associated proteins, including histone deacetylases, 






Homozygous null mutants were generated for two histone deacetylase genes; 
HST1 and HST2 using the methods previously described. One mutant strain 
was generated for HST1 and a pair of mutants for HST2. C. albicans encodes 
a third Hst protein; Hst3, which was not investigated here as it is essential for 
viability [138]. These mutants were used to investigate the roles of histone 
deacetylases on co-chaperone gene expression, which was measured by 
quantitative real-time PCR (qRT-PCR). Co-chaperone gene expression levels 
were compared between the wild type strain and the hst1Δ/Δ and hst2Δ/Δ 
mutant strains.  
 
The objective was to identify clues as to whether there are evolutionary 
mechanisms at work selecting for placement of virulence genes in sub-
telomeric regions due to the specific way their expression is regulated in the 




6.2 Deletion of histone deacetylases affects co-chaperone gene 
expression levels 
 
qRT-PCR was completed with three technical replicates and three biological 
replicates for each gene in each strain, with the housekeeping gene GPD1 
used as a calibrator for ∆CT calculations. All RNA was purified from cells in log 
growth. Results for expression of each co-chaperone gene were analysed first 




between biological replicates, the plot shown is of three technical replicates 
and one biological replicate to simplify the visualisation. Statistical analyses 





Figure 6.1 ∆CT values of co-chaperone genes in wild type strain and histone 
deacetylase null mutants. Shown are three technical replicates with mean and 
standard deviation indicated by crosses and error bars, with normalisation 
against the GPD1 housekeeping gene.  
 
Results show expression of SSA1 was significantly higher in all mutant strains 




deacetylases decreases silencing for SSA1 (Fig. 6.1, Table 6.1). This is the 
only gene for which this was the case in all mutants. 
 
Expression for all co-chaperone genes was higher in the hst1∆/∆ strain, 
YSD1330, relative to the wild type strain, YSD89 (Fig. 6.1). This suggests that 
Hst1 plays an important role in suppressing gene expression of Hsp90 co-
chaperones and that its absence has a significant derepressive effect (Table 
6.1). SBA1 is an exception to this, as its increase in expression relative to the 
wild type strain is not statistically significant (p=0.061). 
 
For the co-chaperones SSA2, SBA1, AHA, and STI1, expression was 
significantly lower in the two hst2∆/∆ strains relative to the wild type strain (Fig 
6.1, Table 6.1). The only exception being SBA1 in YSD1373, for which 
expression was lower than in the wild type strain, but not to a statistically 
significant degree (p=0.086). This is a counter-intuitive result as it would be 
expected that silencing would be reduced as deletion of HST2 would reduce 
chromatin silencing and therefore increase telomeric gene expression. 
However, in S. cerevisiae, deletion of both HST1 and HST2 are known to have 






Table 6.1 P-values of ANOVA and Tukey tests comparing expression of each 
co-chaperone gene between strains. ANOVA tested for variation between all 
strains, while Tukey test shows pairwise comparisons of each mutant strain 




















YSD89 Wild type - 
YSD1330 hst1∆/∆ <0.001*** 
YSD1373 hst2∆/∆ 0.001** 
YSD1414 hst2∆/∆ <0.001*** 
SSA2 
<0.001*** 
YSD89 Wild type - 
YSD1330 hst1∆/∆ 
0.015* 
YSD1373 hst2∆/∆ 0.011* 
YSD1414 hst2∆/∆ 0.028* 
SBA1 0.002** 
YSD89 Wild type - 
YSD1330 hst1∆/∆ 0.061 
YSD1373 hst2∆/∆ 0.086 
YSD1414 hst2∆/∆ <0.001*** 





It is difficult to determine precisely the effects of each histone deacetylase on 
expression of the co-chaperone genes due to the number and complexity of 
interactions in the cell. These assays were designed specifically to measure 
only expression of co-chaperone genes; further work will be needed to fully 
understand these effects. In S. cerevisiae Hst1 is known to suppress 
expression of the genes responsible for biosynthesis of NAD+, meaning that 
in hst1∆ mutants NAD+ is more abundant and paralogous NAD+-dependent 
histone deacetylases are more active in silencing [225].  
 
It cannot be ignored that there is some disparity between the two hst2∆/∆ 
strains, YSD1373 and YSD1414. The difference in expression is statistically 
significant for the genes SBA1 (p=0.003), AHA1 (p<0.001), and STI1 
(p<0.001). Expression of SSA1 and SSA2 in the two strains is statistically 
similar (p=0.414 and p=0.486, respectively). The genotyping method used was 
YSD1330 hst1∆/∆ 0.008** 
YSD1373 hst2∆/∆ <0.001*** 
YSD1414 hst2∆/∆ <0.001*** 
STI1 
<0.001*** 
YSD89 Wild type - 
YSD1330 hst1∆/∆ 0.028* 
YSD1373 hst2∆/∆ 0.014* 




colony PCR, so absence of the wild type allele and of the NAT cassette used 
in transformation is confirmed. However, these results suggest that other 
genetic changes have arisen in the strains during transformation and so in 




6.3 Histone deacetylase activity is dependent on paralogous histone 
deacetylase activity 
 
In addition to gene deletion studies, more of the function of the Hst proteins 
may be elucidated through investigating the effects of overexpression. This 
approach, though, is also not without its complications as NAD+ biosynthesis 
has been found to be the limiting factor in activity of NAD+-dependent histone 
deacetylases in mammalian cells [226]. Overexpression of these enzymes 
therefore does not guarantee a subsequent increase in their activity, unless 
additional NAD+ requirements are also catered for. Especially as 
overexpression of Hst1 is likely to result in reduced production of NAD+ in the 
cell [225]. 
 
There is some overlap in function between Hst1 and Hst2 in C. albicans, as 
both are known to have H3 histone deacetylase activity [72], so there may be 
a similar effect of NAD+ depletion by deletion of HST2 in C. albicans as there 




the loss of Hst2 by upregulating Hst1 to excess, which would account for the 
increased silencing effect observed.  
 
Alternatively, if Hst2 activity is responsible for a great deal of chromatin 
formation, widespread derepression caused by its absence may overwhelm 
the gene expression machinery, resulting in proportionally lower expression 
for Hsp90 co-chaperones. 
 
There may be some functional redundancy with Hst1 and Hst3; the essential 
Hst protein in C. albicans as both have H4 histone deacetylase activity. 
Although both have additional divergent clients, their shared functions may 
mean that the effects HST1 gene deletion are buffered. There is thus far no 
evidence for functional redundancy with Hst2 and Hst3, though Hst1 and Hst2 
do share some clients, as described previously [72].  
 
Perhaps, as an essential gene, the function of Hst3 is also instrumental in the 
expression of the Hsp90 co-chaperones. An approach of chemical depletion 
or augmentation of Hst3 protein levels may help to elucidate its effects whilst 
maintaining cell viability. Hst3 is however non-essential in Saccharomyces 
cerevisiae, and studies of null mutants have found that deletion of HST3 
decreases chromatin silencing [224]. Conversely, while deletion of HST1 
increases silencing in S. cerevisiae the result here was to reduce silencing of 
co-chaperone genes in C. albicans, so extrapolation of effects observed in S. 





Opposing effects of deletion of paralogous genes HST1 and HST2 were not 
anticipated, though there are clues to their dissimilarities in function. 
Orthologues of Hst1 in mammals and in S. cerevisiae are exclusively nuclear 
proteins, whereas Hst2 is also cytosolic; this is also putatively the case in C. 
albicans [72, 227]. The implications of this are not fully understood, but it may 
indicate a broader range of functions for Hst2 than Hst1, and therefore differing 
effects of gene deletion. 
 
Candida albicans Hsp90 co-chaperones appear to be subject to TPE 
silencing, though complex genetic interactions mean that more work is needed 
to fully understand the mechanisms involved. The pliant nature of this type of 
regulation of expression lends itself to rapid response to changeable 
environmental conditions, which is essential in virulence [106]. This is a strong 
argument for placement of virulence genes, including Hsp90 co-chaperone 











7.1 Genome sequencing of co-chaperone gene deletion mutants and 
avoiding second-site mutations in future 
 
The most important piece of future work to be completed is genome 
sequencing of the co-chaperone gene deletion mutants to identify second-site 
mutations which occurred in the transformation process. Comparing the 
genomes of these strains to the wild type would help to elucidate the reasons 
behind the discrepancies in phenotypes observed in the assays found here. 
This would also provide an opportunity to begin understanding how virulence 
was attenuated in the ssa1∆/∆ mutant YSD662 and whether the phenotypes 
constitute a novel discovery of gene function in combination with the absence 
of SSA1. The inconsistencies encountered here highlight the necessity of 
generating at least two independent mutants for each gene deletion to 
corroborate results [228]. 
 
Homologous recombination using the lithium acetate method is a well-
established and reliable means of generating homozygous null mutants. 
However, with its inefficiency and propensity to produce second-site mutations 
and in the advent of CRISPR, moving onto the more modern method of 
generating mutants would be advisable for future work [165, 229]. The 




to be generated much more rapidly, thus allowing for more time to be devoted 
to characterising multiple mutants and confirm phenotypic effects. 
 
In addition to identifying additional mutations arising in the transformation 
process, functions of deleted genes can be further confirmed by replacing the 
wild type allele into the mutant strains, followed by testing for restoration of the 




7.2 Biofilm formation and adherence relies on the function of Hsp90 co-
chaperones 
 
That all mutant strains were significantly impaired in biofilm formation and 
adherence suggests that regulation of this virulence trait is multifactorial and 
highly dependent on functionality of the Hsp90 co-chaperone complex. 
Although most strains formed wrinkled colonies on solid growth media, 
indistinguishable in morphology from that of the wild type, biofilm adherence 
was additionally challenged in the biofilm virulence assay. Further work and 
alternative quantification methods are necessary to deconstruct the 
interconnected pathways responsible for biofilm formation and adherence.  
 
Metabolic activity in biofilms could be measured by colorimetric dye reduction, 
as was done here with XTT [157], with modification made to the wash steps to 




separately by flow cytometry [230], to disentangle biofilm formation and 
adherence. This is important as it is established that biofilm adherence 
capability and potency of C. albicans infections often do not correlate, while 




7.3 Sti1 and Sba1 are promising candidates for further study as potential 
novel drug targets 
 
Sti1 makes a promising candidate for a possible future drug target in a 
combinatorial therapy approach with other antifungal drugs. The protein is 
known to be required for biofilm formation in S. cerevisiae, which has been 
found here to also be the case in C. albicans [201]. It has been found 
previously that Sti1 regulates resistance to radicicol, which was confirmed 
here, in addition to Sti1 regulating fluconazole resistance [193]. As deletion of 
STI1 partially abrogated C. albicans virulence in M. sexta, it would be pertinent 
to assay the effects of fluconazole treatment in an infection model infected with 
sti1∆/∆ strains to assess whether this increased susceptibility translates to the 
host environment. As a function of Sti1 is to mediate between Hsp90 and 
Ssa1/2, the effect of its gene deletion may be to undermine functioning of 
several forms of the Hsp90 co-chaperone complex, resulting in the observed 





C. albicans Sba1 was previously known to regulate telomere maintenance; 
implicating it in cell aging, and to be more highly expressed in stress conditions 
[72, 120]. Here, it has also been shown to be implicated in virulence, as null 
mutants were more susceptible to fluconazole, less able to form biofilms, and 
slower to kill M. sexta larvae than the wild type. These aspects may, like Sti1, 




7.4 Aha1 has an important but uncharacterised role in C. albicans 
virulence 
 
Findings in this study for the co-chaperone Aha1 are particularly interesting. 
C. albicans Aha1 levels were known to be upregulated in oxidative stress [15], 
but Aha1 has been shown here to be non-essential for an effective oxidative 
stress response. Having shown a defect only in biofilm formation, aha1∆/∆ 
strains then exhibited the most attenuated virulence in the invertebrate host. 
This demonstrates that Aha1 function is intrinsically linked to virulence, though 
which specific aspects of virulence it regulates were not fully elucidated here. 
 
This may be investigated in future with assays of other individual virulence 
traits in vitro, such as iron sequestration, or ex vivo assays, such as host cell 
invasion. The effects of loss of Aha1 in the host may also be further dissected 
by analysing M. sexta haemolymph samples during the course of the infection, 




7.5 Hsp70 orthologues are highly conserved in sequence but differential 
in function 
 
The Hsp70 orthologues in C. albicans; Ssa1 and Ssa2 appear to have 
surprisingly differential roles considering their 87.2% protein sequence identity 
[116]. However, Ssa1 is known to mediate host cell invasion and to be required 
for virulence in a murine infection model [110, 118]. If, therefore, it is proposed 
as a potential drug target, it is essential to understand the effects of inhibition 
on Ssa1 and Ssa2 simultaneously, as it is highly unlikely that a compound 
could be developed with adequate specificity to target one exclusively, given 
their conservation. With this in mind, Hsp70 orthologues may not be advisable 
as drug targets as the presence of the Ssa1/2 proteins is instrumental in 
making C. albicans cell vulnerable to the host immune system as well as to 
some antifungal drugs. Inhibition of Ssa2 may have the unfortunate 
consequence of undermining the host immune system [196]. However, 
caspofungin is an antifungal drug in common use and known to suppress 
expression of Ssa2 [197]. 
 
A double null mutant for both Hsp70 orthologues could not be generated in 
this study, which may indicate that the presence of at least one is required for 
C. albicans viability. Measuring the Ssa1 and Ssa2 protein expression levels 
in strains which are homozygous null for one of the genes would be a useful 
step in assessing whether there is compensatory upregulation of one Hsp70 
orthologue in response to the absence of the other. This would provide clues 





From the results presented here it can be concluded that Ssa2, unlike Ssa1, 
is a negative regulator of several virulence traits, though the derepression of 
virulence has an overall fitness cost for the cells in the invertebrate host model. 
Having outperformed the wild type in oxidative stress resistance, antifungal 
drug resistance and hyphal formation the ssa2∆/∆ mutants killed M. sexta 
larvae significantly more slowly than the wild type strain.  
 
The results of this study are inconclusive as to the role of Ssa1. The absence 
of the SSA1 wild type allele was confirmed in both YSD661 and YSD662, but 
second-site mutations in the genome are yet to be identified. However, as both 
strains were the most impaired in killing of M. sexta relative to the wild type, it 
seems likely that Ssa1 promotes virulence. This is in keeping previous findings 
that C. albicans ssa1∆/∆ strains are less virulent in a murine model of 








7.6 Manduca sexta larvae are a useful model of fungal infection 
 
Use of Manduca sexta fifth instar larvae has proven a useful tool for measuring 
virulence in a whole animal infection model. Despite their limitations, they 
make a relevant and low-cost alternative to vertebrate models of infection for 
preliminary studies. They are now established as a novel invertebrate model 
of fungal infection, allows assays to run at the physiologically relevant 
temperature of 37°C. Refinement of the infective dose of yeast cells would be 
useful to spread the infection over a longer timescale. This would allow for 
more morbidity data to be gathered before the animals succumb to infection 
and hence more complete statistical analyses to be carried out. Having 
animals infected with the wild type strain survive beyond day one of the study 
would also allow for detection of enhanced virulence in other strains, as well 
as reduced virulence. 
 
The model also has potential for more diverse analyses, such as sampling of 
faeces or haemolymph over the course of the infection to monitor the fungal 
burnden and whether infection is ever cleared [160]. However, this host is 
physiologically dissimilar to humans in many ways, which should be kept in 
mind. Any promising results from M. sexta infection studies will need to be 







7.7 Hsp90 co-chaperone inhibition in combination with existing 
antifungals requires more exploration in the context of evolutionary 
medicine 
 
Ssa1, Sba1, and Sti1 have all been shown here to positively regulate C. 
albicans resistance to fluconazole, as null mutants were susceptible to lower 
doses than the wild type strain. This may be useful in considering Hsp90 co-
chaperones as drug targets in combinatorial therapy to simply extend the 
efficacy of existing antifungal drugs. C. albicans chaperones have recently 
been shown to be instrumental in antifungal drug resistance mechanisms 
[232]. With this in mind, it would be prudent to also complete caspofungin MIC 
assays on Hsp90 co-chaperone null strains to gather a more complete picture 
of how and to what extent Hsp90 co-chaperones specifically regulate the drug 
response. 
 
Combinatorial therapy is gaining favour as a method to subvert drug resistance 
and extend a drug’s usefulness, whereas cycling treatment with individual 
antimicrobials has been demonstrated to be ineffective, and even in some 
cases accelerates development of resistance [233, 234]. Choosing the 
appropriate combinations of drugs to administer is crucial. While targeting the 
C. albicans stress responses has proven useful in this context, it follows that 
undermining the pathogen’s virulence potential, through targeting Hsp90 co-
chaperones, would also be of benefit [235]. Despite demonstration of the 
efficacy of combinatorial therapy using existing antifungals coupled with 




sequence conservation of human and C. albicans Hsp90 means that there is 
a high risk of host toxicity in administering Hsp90 inhibitors to treat systemic 
fugnal infections. In addition, multidrug-resistant strains of C. albicans 
continue to emerge, and highlight the necessity for new treatment options 
which will discourage C. albicans from developing resistance and thus remain 




7.8 Employing the principles of evolutionary medicine is the next step in 
addressing the problem of infectious diseases and drug resistance 
 
Use of antimicrobials drives the, by necessity, the evolution of widespread 
resistance; persistent and liberal application of antimicrobials eliminates 
susceptible competitors, thus giving the advantage to resistant cells [238]. 
Most applications of evolutionary medicine to infectious disease to date have 
focused on the careful management of existing antimicrobials to minimise the 
emergence and spread of resistance [239]. What is proposed here as an 
alternative is the development of antivirulence drugs, to undermine the ability 
of the infective organism to cause disease, without aiming to kill it or affect 
normal growth. There is some limited precedence to this concept, possibly 
owing to the cost and complexity of developing novel drugs through to 





Under the conditions tested here, none of the Hsp90 co-chaperones 
investigated appear to be essential for robust growth of C. albicans, adhering 
to the principle of evolutionary medicine that the potential drug targets should 
be essential only for virulence. Before pursuing these candidates further, 
however, it would be pertinent to test them in alternative growth conditions, 
more closely imitating their natural environs. Overall, the robust growth of the 
mutant strains, coupled with their inhibited virulence, suggests that as a group 
they do indeed play a significant role in C. albicans virulence and may make 




7.9 Histone deacetylases regulate Hsp90 co-chaperone expression while 
they are sub-telomerically located 
 
Testing the effects of histone deacetylases on Hsp90 co-chaperone 
expression on in log phase cells gives preliminary clues as to their 
involvement. Indeed, the results presented here demonstrate that co-
chaperones are subject to regulation by Hst1 and Hst2. However, Hsp90 co-
chaperone gene expression in histone deacetylase null mutants should also 
be measured and compared in virulence conditions to assess their roles 
specifically in virulence and how they respond to environmental cues. Hst1 
and Hst2 clearly have a significant effect on expression of Hsp90 co-
chaperones, and TPE (telomeric position effect) regulation allows for the rapid 





The influence of TPE regulation on expression of Hsp90 co-chaperones could 
be further investigated by cloning and relocating co-chaperone genes. 
Relocating genes whilst maintaining them on their native chromosome arm, 
away from the telomere and closer to the centromere, along with their 
upstream regulatory regions, would provide the means to observe the effect 
of genomic locale on gene expression.  
 
Mutants with centromerically-located Hsp90 co-chaperone genes should then 
be assessed for their performance in virulence conditions. Likewise, 
expression of Hsp90 co-chaperones should be measured in these strains to 
assess whether expression levels are dependent on gene location. This would 
aid in understanding to what extent sub-telomeric gene location and silencing 




This study represents a methodical approach to understanding the roles of 
Candida albicans Hsp90 co-chaperones and their genomic locale in diverse 
virulence traits. The results presented here have implications for future 
development of novel antifungal drug targets and elucidation of virulence 









Appendix 8.1 Strains used in this study. YSD is the accession code preceding 
numbers for yeast strains in the Diezmann laboratory yeast strain archive. 






































STRAIN GENOTYPE DERIVED FROM 
YSD731 






































STRAIN GENOTYPE DERIVED FROM 
YSD1330 








arg4 /arg4 his1 /his1 URA3/ura3 







Appendix 8.2 List of materials and suppliers used here. 
 
PRODUCT DESCRIPTION SUPPLIER 
2X PCR MASTERMIX Mix for PCR Quantig 






AGAR For solid growth media Fluka 
AGAROSE DNA/RNA gels Sigma 
AMMONIUM SULFATE Media supplement Sigma 
BLUE JUICE LOADING 
DYE 
DNA gel loading dye Invitrogen 
BOVINE SERUM Hyphal induction Fisher 
BOVINE SERUM 
ALBUMIN 
Media supplement Sigma 
CALCOFLUR WHITE Media supplement Sigma 
CONGO RED Media supplement Sigma 




PRODUCT DESCRIPTION SUPPLIER 
D-GLUCOSE Media supplement Melford 
DITHIOTHEITOL Transformations Sigma 
D-MALTOSE 
MONOHYDRATE 
Media supplement Sigma 
DMSO Solvent VWR 
DNTP MIX PCR reagent Fisher 
DOXYCYCLINE Antibiotic Melford 
ETHANOL Solvent Sigma 
FLUCONAZOLE Antibiotic Sigma 
GELDANAMYCIN Hsp90 inhibitor Melford 
GLYCEROL Used in -80°C stocks Sigma 
HYDROCHLORIC ACID pH adjustment Fluka 
HYDROGEN PEROXIDE Oxidating agent Sigma 
L-ARGININE 
MONOHYDROCHLORIDE 








PRODUCT DESCRIPTION SUPPLIER 




LURIA BROTH Growth medium Invitrogen 




NOURSEOTHRICIN Antibiotic Werner BioAgents 
NUTRIENT BROTH Media supplement Oxoid 







PRIMERS PCR reagent Eurofins 
Q5 PCR REACTION 
BUFFER 
PCR reagent NEB 




PRODUCT DESCRIPTION SUPPLIER 
RADICICOL Hsp90 inhibitor Sigma 
RNEASY MINI KIT RNA purification QIAgen 
RNASE-FREE DNASE 
KIT 
RNA purification QIAgen 
RNASE-FREE WATER PCR reagent Invitrogen 
RPMI MEDIUM 1640 Media supplement Gibco 
SALMON SPERM DNA Transformations Applichem 
SODIUM ACETATE DNA purification Sigma 
SODIUM HYDROXIDE pH adjustment Sigma 
SYBR FAST GREEN 
MASTER MIX 
PCR reagent Fisher 
SYBR SAFE DNA gel dye Invitrogen 
TE BUFFER (10X) Buffer Rockland 
TRACK IT 1KB PLUS 
LADDER 
DNA ladder Invitrogen 
URIDINE Amino acid Sigma 




PRODUCT DESCRIPTION SUPPLIER 
YEAST EXTRACT Media supplement Oxoid 























Appendix 8.3 Primers used in strain construction and genotype screening. “-
100” indicates the primer sequence is complementary to a region beginning 
100 bases upstream of the start codon of the gene named. “+100” indicates 
the primer sequence is complementary to a region beginning 100 bases 
downstream of the start codon. “F” and “R” indicate whether the primer runs 
forwards, or reverse respectively; all are presented in 5’ to 3’ orientation. Long 
primers were used for amplification of the NAT cassette prior to transformation; 
upper case sections of the sequence are complementary to the flanking 
regions upstream and downstream of the native genes in C. albicans, while 
lower case sections of sequence are complementary to the NAT cassette 
itself. Short primers were used for genotyping through colony PCR; testing for 

























































































































































Appendix 8.4 Recipes for solid growth media used in morphology assays. All 
ingredients were dissolved in a final volume of 1 L distilled water and sterilised 
either by autoclaving or by filtering through a 0.22 µm filter, as appropriate. 





10 g Oxoid enriched nutrient broth 
10 g Mannitol 
2 g dipotassium phosphate 
10 g agar 
RPMI agar 
pH 7.0 
10.4 g RPMI 
34.35 g 3-(N-morpholino)propanesulfonic acid 
(MOPS) 
20 g glucose 
20 g agar 
Basic SD agar 1.79 g YNB (without added amino acids of 
ammonium sulphate) 
5 g ammonium sulphate 
1.92 g yeast synthetic dropout media (without 
added uracil) 
80 mg uridine 
20 g glucose 
20 g agar 
SD with Calcoflur 
White 
Calcoflur White MR2 powder added to SD agar to 
a final concentration of 150 µg mL-1 
SD with Congo Red Congo Red powder added to SD agar to a final 




5 g ammonium sulphate 
200 mg magnesium sulphate heptahydrate 
2.5 g dipotassium phosphate 







12.5 g glucose 
500 mg L-alanine 
1.3 g L-leucine 
1 g L-lysine hydrochloride 
100 mg L-methionine 
71.4 mg L-ornithine 
500 mg L-phenylalanine 
500 mg L-proline 
500 mg L-threonine 
50 mg L-arginine hydrochloride 
20 mg L-histidine hydrochloride 
1 mg Biotin 
20 g agar 
YPD agar 20 g yeast extract 
10 g peptone 
20 g glucose 






Appendix 8.5 Manduca sexta larvae food recipe. The chlorotetracycline and 
formaldehyde are antimicrobial ingredients used to prevent infections in the 
colony. Formaldehyde was omitted from the food of animals used in infection 






Premix 2700 g Wheatgerm 
1260 g Casein 
1080 g Sucrose 
540 g Dried yeast 
360 g Wesson’s salt 
36 g Choline chloride 
72 g Cholesterol 
36 g Methyl paraben 
54 g Sorbic acid 
Complete food 336 g Premix 
1770 mL Distilled water 
22.5 g Agar 
4 mL Corn oil 
4 mL Linseed oil 
8 mL 4% Formaldehyde 
0.2 g Chlorotetracycline 
0.2 g Vanderssant vitamins 




Appendix 8.6 Primers used in qRT-PCR. “F” indicates the primer is forwards; 



















Appendix 8.7 Growth metrics indicated as a proportion of the wild type metrics 
from their respective repeats. “K” indicates carrying capacity of the culture, 
which is quantified by the maximum optical density the culture reached. “R” 
denotes the overall rate of growth, while “T_gen” is the shortest doubling time 
to occur during the assay.  
CONDITION STRAIN K R T_GEN 
YPD 30C 
YSD661 0.999 0.971 1.030 
YSD662 0.984 0.925 1.082 
YSD702 0.945 1.010 0.991 
YSD731 0.978 0.939 1.065 
YSD813 1.001 0.975 1.025 
YSD816 1.026 0.981 1.019 
YSD868 1.053 0.971 1.030 
YSD871 1.045 0.971 1.030 
YSD874 1.031 0.961 1.041 
YSD947 0.991 1.080 0.927 
YNB 30C 
YSD661 1.003 1.066 0.939 
YSD662 1.175 0.988 1.012 
YSD702 1.007 1.000 1.000 
YSD731 1.010 0.990 1.010 
YSD813 0.987 1.036 0.965 
YSD816 1.085 0.976 1.025 
YSD868 1.072 0.955 1.046 
YSD871 1.067 1.004 0.996 
YSD874 1.047 0.914 1.094 






CONDITION STRAIN K R T_GEN 
YPD 37C 
YSD661 1.006 1.008 0.992 
YSD662 0.995 1.233 0.811 
YSD702 0.935 0.880 1.137 
YSD731 0.911 0.800 1.251 
YSD813 0.963 0.914 1.095 
YSD816 1.040 0.863 1.160 
YSD868 0.999 0.895 1.116 
YSD871 1.064 0.865 1.157 
YSD874 1.004 0.839 1.193 
YSD947 1.001 0.836 1.197 
YNB 37C 
YSD661 1.034 1.050 0.953 
YSD662 1.007 1.057 0.945 
YSD702 0.985 1.060 0.944 
YSD731 1.047 1.076 0.929 
YSD813 0.877 1.169 0.855 
YSD816 1.005 1.215 0.824 
YSD868 1.071 1.193 0.839 
YSD871 1.106 1.126 0.888 
YSD874 1.029 0.813 1.231 
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